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Cervical cancer is a virally mediated disease with the majority of cases due to the human
papillomavirus (HPV). HPV infections are the most prominent sexually transmitted diseases
among college women. Although vaccines such as Gardasil afford women with a valuable
method of cancer prevention, vaccination rates are often incomplete or inadequate. This study
evaluated the effectiveness of an interactive, information-motivation-behavioral skills (IMB)
based, multimodal program to promote Gardasil use among 62 undergraduate women enrolled at
the University of Connecticut. Secondary aims targeted additional health behaviors, including
risky sexual practices and Pap Screen utilization. Participants were randomly assigned to a
single-session intervention group or an attention control group and were assessed pre- and postintervention and at a 1-month follow-up. At baseline, a majority of women demonstrated high
levels of vaccine knowledge, low mastery of HPV/cervical cancer information, and ambivalence
about pursuing vaccination. Following the intervention, the IMB group demonstrated increased
levels of HPV/cervical cancer and Gardasil knowledge, higher levels of motivation and
intentions to get vaccinated, and more positive attitudes toward vaccination. Women in the IMB
group also demonstrated greater intentions to engage in regular screening. These results provide
support for an IMB program to impact women’s decision to get vaccinated and engage in cancer
prevention. Findings may help guide the development of a cost-effective, cancer preventive
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program that can be easily disseminated and implemented in university clinics and health
centers.
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Cervical cancer is one of the most prevalent forms of cancer diagnosed in women
globally (Collins, Einstein, Gostout, Herzog, Massad, Rader, et al, 2006). The economical and
societal burden of this disease is substantial, as it is estimated that approximately 12,000 new
cases and about 4,000 deaths will occur each year in the United States (Center for Disease
Control and Prevention (CDC), 2011a). There are several risk factors that have been posited to
increase women’s susceptibility to developing cervical carcinoma, including smoking, diet,
immunosuppression, use of birth control pills, and giving birth to more than 3 children
(American Cancer Society (ACS), 2010). Of these multiple risk factors, infection with Human
Papillomavirus (HPV) has been evidenced to be one of the primary causes of cervical cancer
(Collins et al, 2006; Franco, Schlecht, & Saslow, 2003).
HPV are a family of over 150 small, double-stranded DNA viruses, of which 40 are
characterized as sexually transmissible. These genital subtypes are further categorized as high
risk or low risk based on their oncogenic properties, with high risk strains implicated in cancers
of the cervix, vulva, anus, and penis (Veldhuijzen, Snijders, Reiss, Meijer, & van de Wjgert,
2010) and low risk HPV leading to genital warts (National Cancer Institute (NCI), 2011).
Amongst the 15 high-risk, cancer-causing strains, subtypes 16 and 17 are the most common and
have been linked to 70% of cervical cancers (NCI, 2011).
The evidence depicting cervical cancer as a virally mediated disease is indisputable;
studies have shown that 99.7% of all cases of cervical cancer have confirmed HPV DNA
(Montalvo, Lobato, Villanueva, Borquez, Navarette, Abarca, et al, 2011). Sexual contact with an
infected person transmits the virus through micro-abrasions in the cervix, infecting the basal cells
of the cervical epithelium. Subsequent invasion of the host cell yields expression of several
viral-specific oncogenic proteins, particularly E6 and E7, whose main function is to disable vital
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tumor suppressing agents thereby enabling unrestrained aberrant cell replication (Jensen,
Lehman, Antoni, & Pereira, 2007; Veldhuijzen et al, 2010). These cellular changes in the cervix
are often transient; in fact, a healthy immune system is capable of effectively eliminating the
virus from the body within 2 years of infection (CDC, 2011a). However, persistent infection
with high-risk strains facilitates integration of viral DNA into the host genome leading to lasting
cellular transformations (Jensen et al, 2007). If left untreated, these cellular changes accelerate
disease pathogenesis and ultimately become cervical cancer.
Prevalence and Awareness of HPV
HPV infection of the anogenital region is highly communicable. Established as one of
the most common sexually transmitted diseases (Garcia & Saslow, 2007), as many as 50% of
sexually active individuals are likely to get HPV at some point in their lifetime (CDC, 2011a).
Epidemiological studies have documented a parabolic relationship between age and risk of HPV
infection; specifically, incidence rates have been shown to steadily rise with increasing age,
climax in the mid twenties, and then wane over time (Grant, Dunne, Chesson, & Markowitz,
2011). Accordingly, HPV infections are most prevalent in college aged students, as sexual risk
behaviors are deemed most prominent in this age group (Dunne, Unger, Sternberg, McQuillan,
Swan, Patel, et al, 2007; Grant et al, 2011; Revzina & DiClemente, 2005). Sexually active
females carry the highest rates of infection, with studies documenting rates as high as 68-71% in
young, sexually experienced women (Kahn, Rosenthal, Jin, Huang, Namakydoust, & Zimet,
2008; Smith, Melendy, Rana, & Pimenta, 2008; Villa, 2006). Despite their elevated risk status,
research has documented less than optimal knowledge about HPV (Gerend & Shepherd, 2011;
Klug, Hukelmann, & Blettner, 2008; Waller, McCaffery, Forrest, & Wardle, 2004). One recent
study of 739 unvaccinated female students explored women’s familiarity with HPV-specific
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information. Gerend & Shepherd (2011) found heightened levels of awareness in this population
of young women; in fact, nearly 100% reported some knowledge of HPV. However, closer
examination of the data highlighted important knowledge deficits; specifically, few could
identify the multifarious outcomes of HPV infection (e.g., genital warts), and not many were
privy to the risk of acquiring multiple infections by viral variants (Gerend & Shepherd, 2011). In
addition, nearly 40% of these women were still unable to identify HPV as an underlying causal
agent of cervical cancer as well as acknowledge its status as a sexually transmitted infection
(Gerend & Shepherd, 2011). These findings are corroborated by other studies that find similar,
low levels of factual HPV knowledge in young women (Ingledue, Cottrell, & Bernard, 2004;
Dillard & Spear, 2010; Kobetz, Kornfield, Vanderpool, Finney Rutten, Parekh et al, 2010;
Marek, Dergez, Bozsa, Gocze, Rebek-Nagy, Kricskovics et al, 2009), with the lowest rates
documented in Taiwanese undergraduate women (Hsu, Cheng, Hsu, Fetzer, & Chou, 2011) and
Hispanics (Fernandez, McCurdy, Arvey, Tyson, Morales-Campos, Flores et al, 2009; Ford,
2011; Gerend & Shepherd, 2011; Jain, Euler, Shefer, Lu, Yankey, & Markowitz, 2009;
Vogtmann, Harlow, Cruz Valdez, Cruz Valdez, & Lazcano Ponce, 2011). Particularly
noteworthy, researchers have found evidence for low HPV risk perceptions amongst women in
spite of ongoing sexual activity, further highlighting disparities in HPV knowledge (Krawczyk,
Perez, Lau, Holcroft, Amsel, Knauper et al, 2012). Nonetheless, despite these discrepancies,
young women who are highly educated, report more sexual partners, have a history of prior
infection, and who learned of HPV through the media or a primary care physician evidenced
greater HPV specific knowledge (Dillard & Spear, 2010; Gerend & Shepherd, 2011).
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Interest and Uptake of Gardasil
The advent of HPV quadrivalent vaccines has provided women with a valuable tool to
decrease their overall risk for cervical cancer. Gardasil was approved by the Food and Drug
Administration (FDA) in 2006 for use by women ages 9-26 as a primary cancer preventive tool,
and efficacy studies have shown that it significantly reduces the acquisition of high risk viral
strands implicated in the majority of the cases of cervical cancer (Cummings, Zimet, Brown, Tu,
Yang, Fortenberry, & Shew, 2012; Herzog, Huh, Downs, Smith, & Monk, 2008; Villa, 2006). In
addition, the vaccine affords protection against viral strains that cause 90% of genital warts.
Gardasil is delivered in a series of three, intramuscular injections over a span of 6 months, and it
is postulated to confer its maximum protective function to HPV naïve individuals regardless of
sexual status (American College of Obstetricians and Gynecologists [ACOG], 2010; Cummings
et al, 2012; Lu, Kumar, Castellsaue, & Giuliano, 2011). Naturally, the vaccine is directed at
sexually inexperienced women as it is presumed they are less likely to have acquired one of the
strains simulated in the vaccine (Villa, 2006).
Despite these recent advances, researchers continue to report inoculation rates that are
often incomplete or inadequate (Medeiros & Ramada, 2011; Tan, Viera, Rowe-West, Grimshaw,
Quinn, & Walter, 2011; Wong & Sam, 2010). In fact, a recent report by the CDC asserts that
Gardasil vaccination rates fall short when compared to other recommended vaccines (CDC,
2011b). One study of 428 women determined that only 19% of the sample received at least one
of the three recommended doses of Gardasil (Manhart, Burgess-Hull, Fleming, Bailey, Haggerty,
& Catalano, 2011). Furthermore, among those who initiated, few (10%) completed the series
and less than half of the remaining women reported intentions to get the final doses (Manhart et
al, 2011). In fact, HPV vaccination rates in young women are declining over time (Etter, Zimet,
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& Rickert, 2012). These findings are substantiated by other studies that also document
substandard utilization of Gardasil among young adult women (Ford, 2011; Head & Cohen,
2012; Jain et al, 2009; Vanderpool, Casey & Crosby, 2011). Another retrospective study by Tan
and colleagues (2011) further examined vaccination behaviors in a sample of 138,823 women
aged 9-26. While rates of vaccination were slightly higher in this sample (55%), most notable
was their discovery of age-based differences related to Gardasil use. Specifically, the
researchers determined that women aged 18-26 were less likely to initiate and complete the
series than those aged 13-17 (Tan et al, 2011). Equally disconcerting, the researchers also
discovered general noncompliance with inoculation guidelines, with only 28% of the sample
completing the Gardasil series on time (Tan et al, 2011). There is additional data highlighting
important race-based disparities in vaccination behaviors; in fact, studies report that African
American and Hispanic groups are less likely to initiate and complete the series (Cook, Zhang,
Mullins, Kauf, Brumback, Steingraber et al, 2010; Niccolai, Mehta, & Hadler, 2011; Tan et al,
2011). Specifically, a recent study by Ford (2011) reported vaccination rates for White, Black,
and Hispanic women aged 18-24 to be 23%, 8%, and 6%, respectively. Further support for these
age and race-based discrepancies is found in other exploratory studies (Head & Cohen, 2012;
Jain et al, 2009; Liddon, Leichliter, & Markowitz, 2012; Taylor, Hariri, Sternberg, Dunne, &
Markowitz, 2011).
Given the elevated risk of cervical cancer in women infected with HPV, researchers have
endeavored to develop a general profile of women most amenable to HPV vaccination; however,
the evidence delineating characteristics among those motivated to get vaccinated is variable.
Several key factors have been associated with increased interest in getting the vaccine. In
general, studies have found that women who are White, unmarried, highly educated, have health
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insurance, perceive vaccination behavior as socially acceptable, perceive themselves susceptible
to acquiring HPV, perceive parental and physician support, endorse more positive attitudes, and
are more well-informed about the vaccine typically express greater interest in getting vaccinated
against HPV (Bendik, Mayo, & Parker, 2011; Conroy, Rosenthal, Zimet, Jin, Bernstein, Glynn et
al, 2009; Dillard, 2011; Jain et al, 2009; Krawcyk et al, 2012; Liddon et al, 2012; Manhart et al,
2011; Niccolai et al, 2011; Roberts, Gerrard, Rimer, & Gibbons, 2010; Vanderpool et al, 2011;
Tan et al, 2011; Rosenthal, Weiss, Zimet, Good, & Vichin, 2011; Taylor et al, 2011; Tsau,
Reutzel, Wang, Quinones, Nguyen, Hasan et al, 2011; Zimet, Stupiansky, Weiss, Rosenthal,
Good, & Vichnin, 2011). Less consistent reports have linked drug use, marital status, prior
experiences with Hepatitis B vaccine (Jain et al, 2009), fear of vaccine side effects, and low
cancer risk perceptions to HPV vaccine acceptance (Krawcyk et al, 2012; Manhart et al, 2011;
Vanderpool et al, 2011; Zimet et al, 2011). Of these factors, studies have predominantly found a
role for vaccine knowledge in promulgating interest in getting vaccinated, especially if delivered
by physicians (Zimet, 2005). Vaccine cost has also been presented as a key obstacle to getting
vaccinated, as Gardasil has been evidenced to be more expensive than other recommended
vaccines (Gottlieb, Brewer, Smith, Keating, & Markowitz, 2009; McCave, 2010; Schwartz,
Caplan, Faden, & Sugarman, 2007). Yet, a recent study by Crosby, Casey, Vanderpool, Collins,
& Moore (2011) concluded that more elusive factors may influence women’s decision to
vaccinate. In this study of 18-24 year old women living in Kentucky, Crosby & Colleagues
(2011) distributed a series of vouchers that enabled women to access Gardasil for free. Study
findings determined that less than half the sample exchanged their vouchers for at least one dose
of the vaccine; in particular, the majority of inoculations were most evident in urban sites where
the vaccine was more readily available. The researchers concluded that vaccine accessibility
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might have contributed to these findings, suggesting a role for motivational constructs.
Appropriately, intentions to get vaccinate have been shown to influence vaccine uptake (Hopfer,
2012; Manhart et al, 2011). Lastly, other studies have found support for the role of self-efficacy
in inciting HPV vaccine uptake (Hopfer, 2012). Specifically, vaccine self-efficacy is speculated
to increase confidence in one’s ability to overcome obstacles to getting the vaccine (Hopfer,
2012). In light of these findings, the data suggests that interventions created to stimulate vaccine
interest in these high-risk groups should consider the complex interplay of internal and external
factors that may drive the decision to vaccinate.
Controversy Behind the Vaccine
Clearly, the extant literature has illustrated the value of HPV vaccination in promoting
cervical health. Yet, despite these benefits, the emergence of this vaccine has elicited
considerable controversy regarding its efficacy and impact on health care practices (Nelson,
2007). Fervent debate over the appropriateness of Gardasil vaccination initially arose in
response to state mandates requiring young girls to be vaccinated prior to entering school
(Schwartz et al, 2007). Conservatives argued the movement was premature, citing its novelty as
grounds for questioning its safety and utility (Hopfer & Clippard, 2011; Nelson, 2007; Schwartz
et al, 2007). Additional concerns emerged around the psychosocial implications of vaccination;
specifically, opponents claimed that Gardasil may promote the message that hypersexual
behavior is acceptable (Briones, Nan, Madden, & Waks, 2011; Ohri, 2007; Kollar & Kahn,
2008). Accordingly, studies document increased parental concerns over the possible false sense
of security proffered by the vaccine (Ohri, 2007). In addition to increased sexual risk behaviors,
other critics contend that vaccination will decrease adherence to screening guidelines (Forster,
Wardle, Stephenson, & Waller, 2010; Herzog et al, 2008). Despite these concerns, investigators
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exploring the impact of Gardasil vaccination on health behaviors report no discernible difference
between vaccinated and unvaccinated women (Mather, McCaffery, & Juraskova, 2012). On the
contrary, vaccine completers have been evidenced to maintain safe sex beliefs and screening
requirements in spite of vaccination status (Caskey, Lindau, & Alexander, 2009; Cummings et
al, 2012; Doskoch, 2012). Nonetheless, despite these findings, Gardasil continues to grow
increasingly stigmatized as the public associates HPV infection and vaccination behavior with
sexual promiscuity (Hopfer & Clippard, 2011).
Information-Motivation-Behavioral Skills Model
There is a dearth of research investigating interventions that help stimulate Gardasil use
among women. Most of the interventions that exist have focused on using educational tools and
pamphlets to enhance HPV, cervical cancer, vaccination knowledge, and vaccination attitudes
amongst undergraduate women (Doherty & Graff Low, 2008), high school students (Gottvall,
Tyden, Hoglund, & Larsson, 2010), and parents (Cox, Cox, Sturm, & Zimet, 2010), but few to
date have examined the effectiveness of interventions in increasing vaccination rates, especially
in high risk populations like undergraduate women. Furthermore, even fewer interventions have
been grounded in theory. Only two known studies have developed interventions specifically
targeting vaccine uptake, and results on vaccination rates were mixed. Specifically, Patel,
Zochowski, Peterman, Dempsey, Ernst, & Dalton (2012) determined that an HPV educational
intervention coupled with a mailed reminder at 2 weeks was not successful in inducing vaccine
uptake in a sample of undergraduate women when compared to a standard of care control group.
Conversely, Hopfer (2012) reported success with a brief, peer and expert-led narrative
intervention in increasing uptake, however the authors only measured vaccine initiation and not
completion. Moreover, their sample was older, consisting mostly of women beyond their first

8

year of college, and they demonstrated higher levels of HPV knowledge than found in other
research (Hopfer 2012). Lastly, they do not evaluate the impact of their intervention on other
cervical cancer prevention behaviors.
Fisher and Fisher (1992) created the information-motivation-behavioral skills (IMB)
model (see Figure 1) as a framework to understand and predict health behavior change. Initially
developed to elucidate the factors that influence HIV preventive behaviors, its use as a
comprehensive, theoretically-based model has expanded to include a variety of populations and
health behaviors, including diabetes care, breast cancer screening, and cardiovascular care
(Osborn, Amico, Cruz, O’Connell, Perez-Escamilla, Kalichman et al, 2010; Fisher, Fisher, &
Harman, 2003). The IMB model maintains that information directly related to the target
behavior, personal and social motivation to engage in the target behavior, and related behavioral
skills to accurately execute components of the behavior are all essential precipitants to the
performance of adaptive health behaviors (Fisher & Fisher, 1992; Fisher et al, 2003).
Informational and motivational elements are proposed to be independent constructs that effect
the implementation of health behaviors through their individual influence on behavioral skills;
however, they may engender direct changes in behavior depending on the complexity of the
behavioral skills. Interventions founded on the IMB model address each of these integral
components, which are based on preliminary investigation of the existing deficits in populations
of interest.
Given the burden of HPV infections in this population and the unwavering link between
HPV and cervical cancer, there is an emergent need for the development and testing of theorybased interventions that directly support vaccine-seeking behaviors. The purpose of this study
was to examine the effectiveness of a theory-based, educational program to promote Gardasil use
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among undergraduate women enrolled at the University of Connecticut. In addition, a secondary
goal of this study was to determine the intervention’s capacity to influence additional behaviors
important for cancer prevention, including decreasing risky sexual behavior and engaging in
regular pap smears for HPV detection. It is hypothesized that 1) Women who complete the
intervention will demonstrate greater improvements in knowledge, motivation, and behavioral
skills related to vaccine use in comparison to women who complete the control group; 2) Women
who complete the intervention will demonstrate greater behavioral intentions to pursue Gardasil
vaccination in comparison to women in the control group; 3) Women who complete the
intervention will demonstrate increased uptake of the HPV vaccine and increased practice of
general cancer preventive behaviors, including increasing condom use and regular pap smears.
The results of this study may help improve researchers’ understanding of factors that influence
cervical cancer attitudes and vaccine uptake. In addition, findings may help guide the
development of a cost-effective, cancer prevention program that can be easily disseminated and
implemented in health centers and university clinics.
Methods
Participants and Procedure
This study utilized a 2X3 randomized, controlled design to examine the effectiveness of
an informational-motivational-behavioral skills based intervention in promoting Gardasil use.
Specifically, this study incorporates a third time-point assessed one month post-baseline to
explore behavioral changes consistent with cancer prevention and indicative of vaccine
procurement. Eligible participants were a convenience sample of women, aged 18-26 years, who
were enrolled in an Introductory Psychology course at the University of Connecticut. Students
enrolled in these courses completed a set of university-wide screening measures prior to their
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inclusion in the participant pool; those who completed the HPV vaccination series were excluded
from the study. Women interested in participating self-enrolled for a study session online via the
university subject pool. Study sessions scheduled on the pool calendar corresponded to either an
active intervention or an attention control group; however, participants remained blind to study
condition thereby preserving random group assignment. During the initial session, subjects
completed a consent form, filled out a baseline questionnaire battery, and then participated in
either the control or experimental condition as scheduled. Given the association between vaccine
uptake and perceived social acceptance of Gardasil (Allen, Mohllajee, Shelton, Othus, Fontenot,
& Hanna, 2009), the intervention was delivered in a small-group format to de-stigmatize HPV
infection and normalize HPV vaccination. To maintain equivalence between study conditions,
the same design was utilized for the control subjects. At the conclusion of the study session,
participants completed a posttest questionnaire battery and were reminded of the one-month
follow-up. Approximately 4 weeks after the study baseline, participants were sent an email
containing a link to a brief online survey. All participants received research credit for
participating in either or both study time-points as prearranged by their instructor. Participants
who completed the follow-up survey received a $5 card to the university Co-Op. This study was
reviewed and approved by the University of Connecticut Institutional Review Board.

Experimental group. Consistent with the IMB model, participants randomized to the
educational intervention received information regarding cervical cancer, HPV infection and the
HPV vaccine. Women were first given a Gardasil information sheet that is readily available at
the student health centers and online. Educational materials were presented with slides to address
particular knowledge deficits that have been identified in this population based on a review of
the literature (Allen et al, 2009; Bendik et al, 2011; Caskey et al, 2009; Daley, Vamos, Buhi,
11

Kolar, McDermott, Hernandez, & Fuhrmann, 2010). In particular, participants were provided
with information regarding the prevalence of HPV, methods of transmission, vaccine cost,
safety, efficacy and specific side effects, and the importance of condom use. A series of short
video clips were presented to dispel popular myths associated with the HPV vaccine.
Participants were encouraged to write notes and questions on the slide handouts provided at the
beginning of the session, and the facilitator engaged the group in a discussion at the end of the
informational section.
A second component of the intervention included the use of motivational interviewing
techniques to enhance participants’ motivation to change their behavior, or in this case to get
vaccinated. Motivational Interviewing (MI; Miller & Rollnick, 1991) was utilized to address
motivational components related to vaccine interest. MI is a therapeutic style that focuses on
building an empathic, nonjudgmental, and collaborative environment in efforts to build an
individual’s self-efficacy and intrinsic motivation to change or practice a particular health
behavior. It is built on the premise that people are experts of their own selves, have a specific set
of values that govern their behaviors, and are primarily responsible for inciting self-change
(Emmons & Rollnick, 2006). In accordance with the MI spirit, the entire intervention was
delivered utilizing an air of acceptance, respect, and collaboration. A discrete period
emphasizing motivational strategies followed the informational portion of the intervention, at
which point participants were asked to take 5 minutes to complete a decisional balance sheet
identifying their personal pros and cons of getting vaccinated and highlighting 5 barriers to
vaccination. Following this task, participants separated into smaller groups of 2-3 to discuss
their two lists. After a brief, small-group discussion, participants were engaged in a larger group
discussion and asked to list the top 3 pros, cons, and specific barriers for not getting vaccinated.
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The facilitator wrote these barriers on the board and incorporated several core MI skills,
including asking open-ended questions, providing affirmations, reflective listening, and
providing summaries, to highlight instances of ambivalence and elicit self-change talk. This
segment ended with asking students to think about what it would take to get them to want to get
vaccinated against HPV.
The final element of the intervention consisted of addressing behavioral skills related to
accessing the HPV vaccine. In particular, participants were provided with locations that offer the
vaccine, sites where they can access additional information, questions they should ask their
doctors, and questions they can ask their parents. Given the literature’s emphasis on the role
parental acceptance plays on vaccination intentions (Bartlett & Peterson, 2011), time was spent
providing participants with ways to engage their family in their decision-making process. In
addition, participants were provided with strategies to promote vaccine acquisition and
compliance with the 3 shot series; for instance, participants were directed to use phone, school,
and gmail calendars to schedule appointments and set reminders. Vaccine costs were discussed
along with ways to access the vaccine if insurance coverage is a concern. Additional related
skills that were targeted included how to request and prepare for a pap screen, how often to get a
pap screen according to current guidelines, and how to adopt healthier sexual practices including
condom use. Further tailoring of the intervention was undertaken by problem-solving any
additional obstacles identified by the women during the general group discussion.
Control group. Individuals randomized to the attention control group were given a
Gardasil information sheet that is readily available at the student health centers and online. In
addition, to maintain consistency with the treatment’s presentation format, participants watched a
set of short video clips encompassing aspects of women’s health and sexual health. The videos
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broadly covered topics related to what happens during a sexual health check, ways to improve
access to health services, and methods of contraception. Following the series of clips,
individuals had the opportunity to engage in a brief group discussion and ask questions. In
response, they were directed to particular sections of the videos viewed or to websites readily
available to the public.

Measures
Participants completed a questionnaire battery before and after completing the
intervention or control group as well as one month later. Scales that tap each of the model’s
three dimensions were constructed by drawing questions from other studies of HPV and cervical
cancer and modifying them to create an aggregrate measure that is consistent with instruments
used in studies predicated on the IMB model. The survey also consisted of a collection of
questionnaires adapted from surveys used by the American Cancer Society and the National
Cancer Institute that were readily available online. The questionnaire battery assessed
participants on a number of sociodemographic, personal and familial cancer history, sexual
health behavioral practices, and general health behaviors. Refer to Appendix A for the
questionnaire used in this study.
Primary Measures
Information. Consistent with studies based on the IMB model (Carey, Braaten, Maisto,
Gleason, Forsyth, Durant, et al., 2000; Fisher, Fisher, Bryan, & Misovich, 2002; Fisher, Fisher,
Misovich, Kimble, & Malloy, 1996; Kalichman, Picciano, & Roffman, 2008; Osborn et al,
2010), participants were assessed on their level of knowledge regarding information about HPV,
the HPV vaccine, and cervical cancer. Two questionnaires listed below were utilized to
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determine individuals’ level of factual knowledge and “implicit beliefs” regarding Gardasil,
HPV, and cervical cancer, as these have been demonstrated to influence the target behavior
(Fisher et al, 2003).
HPV vaccine knowledge (Caskey et al, 2009). This scale is a 9-item series of true
or false questions that measure women’s knowledge of the HPV vaccine. Individual items are
summed to arrive at a total scale score ranging from 0-9, and higher scores reflect greater
vaccine-specific knowledge. This questionnaire was developed and utilized in a study that
measured young women’s knowledge and use of the HPV vaccine (Caskey et al, 2009).
Awareness of HPV and cervical cancer questionnaire (Ingledue et al, 2004).
The Awareness of HPV and Cervical Cancer Questionnaire is a 40-item self report battery that
measures two primary domains related to HPV and cervical cancer beliefs. The first domain
assesses knowledge of HPV and cervical cancer, and the second domain measures perceived
threat of HPV and cervical cancer. Perceived threat is further divided into two components:
perceived seriousness and perceived susceptibility. The knowledge dimension consists of 15
factual questions about HPV and cervical cancer. Participants are asked to select the best
response out of 5 options for 5 multiple-choice questions (e.g., Cervical cancer can be diagnosed
by...”), and then they are asked to identify risk factors for cervical cancer via a series of 10 true
or false questions. The number of correct responses is summed to obtain a total knowledge score
ranging from 0-15, and higher scores demonstrate greater knowledge. For the second dimension,
perceived cervical cancer risk is determined by asking participants to rate their level of
agreement with 9 statements (e.g., “I believe that I am at risk for cervical cancer”) on a 5-point
Likert scale from 1 (strongly disagree) to 5 (strongly agree). The nine individual items are
summed to arrive at a total subscale score ranging from 9 - 45, and higher scores reflect greater
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perceived susceptibility for cervical cancer. This portion of the scale will be used as one of the
five indices of motivation. Lastly, the third subscale measures perceived seriousness by asking
participants to identify their agreement with 6 statements (e.g., “All women who develop
cervical cancer must have their uterus removed”) on a 5-point Likert scale from 1 (strongly
disagree) to 5 (strongly agree). Individual items are summed to arrive at a final subscale score
ranging from 6-30, with higher scores indicative of greater perceived seriousness. The internal
consistency for each of the subdomains was fairly adequate, with ! = .70 for knowledge and ! =
.76 for perceived susceptibility. Internal consistency for perceived seriousness was quite low (!
= .40). Scale authors did not report internal consistency values in their review of the scale;
however, the questionnaire was developed, utilized and validated in research with a college
student population (Ingledue et al, 2004).
Motivation. Consistent with studies based on the IMB model (Carey et al., 2000; Fisher,
et al, 2002; Fisher et al, 1996; Kalichman et al, 2008; Osborn et al, 2010), motivation to get
vaccinated was assessed through five questionnaires to measure different aspects of motivation:
perceived motivation, attitudes related to getting vaccinated, perceived social norms to getting
vaccinated, behavioral intentions, and perceived risk for HPV/cervical cancer.
Motivation Self-Rating. This self-report scale is a modified version of a scale
used in Kalichman et al (2008). Participants are asked to rank how motivated they would be
from 1 (not at all) to 4 (very strong) to get the vaccine. Higher ratings denote greater levels of
motivation to get the vaccine.
Attitudes toward getting vaccinated. This self-report measure is a modified
version of a scale used by Fisher and colleagues (1996). Participants were asked to rate their
agreement with seven behaviors related to getting vaccinated (e.g., getting more information
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about HPV vaccine; getting the HPV vaccine in the next month; discussing HPV with friends) on
three, 5-point Likert scales (e.g., good-bad, nice-awful, pleasant-unpleasant). These items were
summed to create a final measure of attitudes toward getting vaccinated ranging from 21-105,
with higher scores denoting more negative attitudes. The internal consistency for this measure
was high (! = .95) and consistent with other studies (Fisher et al, 1996).
Perceived social norms. This scale was also modeled after a measure of social
norms used by Fisher and colleagues (1996). Participants’ perception of social convention
related to getting vaccinated was assessed by asking participants to rate their agreement with
seven behaviors associated with getting vaccinated (e.g., getting more information about HPV
vaccine; getting the HPV vaccine in the next month; discussing HPV with friends) on a 5-point
Likert scale (very untrue to very true). Scale items were summed to arrive at a final measure of
perceived social norms ranging from 7-35; higher scores reflect greater perceived social norms.
The Cronbach’s alpha for this scale (! = .91) was consistent with Fisher et al’s (1996) measure
used in other college populations.
Behavioral intention. Participants were asked a set of 7 questions about their
intentions regarding getting more information about the vaccine, discussing the HPV vaccine
with their friends, and actually getting the HPV vaccine within the next year and/or within the
next 3 years. The first question specifically asks participants about their commitment to getting
vaccinated in the next year, and response options included “undecided”, “I do not want to get the
vaccine”, and “I want to get the vaccine.” For the purposes of analysis, these responses were
reordered to reflect contemplative movement, with “I do not want to get the vaccine” categorized
as 0, “undecided” as 1, and “I want to get the vaccine” as 2. For the remaining six questions,
participants were asked to rate their intentions to engage in each of the vaccine-seeking
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behaviors on a 6 point Likert scale, from 1 (very unlikely) to 6 (very likely). This scale was
modeled after a study aimed to reduce AIDS risky behavior in a college student population
(Fisher et al, 1996), and questions were drawn from a measure used in Gerend, Lee & Shepherd
(2007) to assess personal acceptability of the HPV vaccine. The seven items were summed to
arrive at a final score ranging from 6 to 39. Higher scores reflect greater intentions to get the
HPV vaccine. The internal consistency (! = .89) for this scale is concordant with that found in
Fisher and colleagues’ (1996) college student population.
Behavioral skills. Consistent with studies based on the IMB model (Carey et al., 2000;
Fisher et al, 2002; Fisher et al, 1996; Kalichman et al, 2008; Osborn et al, 2010), participants’
belief and confidence in their ability to get vaccinated were assessed.
Perceived efficacy. Modeled after Fisher and colleagues (1996), participants
were asked to rate how effectively they would be able to carry out nine behaviors associated with
getting vaccinated (e.g., how effectively can you get vaccinated completely against HPV; how
effectively can you find the time to go to your health provider for three visits to get vaccinated
against HPV; how effectively are you in affording to get vaccinated against HPV, etc) on a 5point Likert scale. Response options included 1 (very ineffectively) to 5 (completely
effectively), and the scale was averaged to arrive at a final scale score ranging from 1 to 5.
Higher scores reflect greater perceived skills to get vaccinated, and Cronbach’s alpha was high
(! = .86).
Perceived difficulty. Consistent with Fisher et al (1996), participants were asked
to rate their perceived difficulty from 1 (very hard to do) to 5 (very easy to do) in carrying out
nine behaviors associated with getting vaccinated (e.g., how difficult would it be to get
vaccinated completely against HPV; how difficulty would it be to find the time to go to your
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health provider for three visits to get vaccinated against HPV; how difficult would it be to afford
to get vaccinated against HPV, etc). Scale items were averaged to create a final score, with
higher values indicative of greater perceived barriers. This measure demonstrated good internal
consistency for this study (! = .83).
Cervical cancer preventive behaviors. Participants were asked a series of 9 yes/no
questions to explore performance of several key cervical cancer preventive behaviors, including
taking steps to get screened and taking steps to learn more about or access the HPV vaccine, at
two time-points (i.e., pre-intervention and one-month follow-up). One question inquired about
frequency of condom use on a 7-point Likert scale, with response options ranging 0 (not
applicable) to 6 (always). For the purposes of analyses, individuals who responded to this
question as not applicable and thus not sexually active were considered as engaging in sexually
protective behavior; henceforth they were grouped into the category identified as
frequent/always condom use. Prior to analysis, this question was further categorized by
collapsing response options into three, increasing categories: none to rare condom use (0-points),
occasional condom use (1-point), and frequent condom use/not sexually active (2-points). All
ten items were then summed to arrive at a final cancer preventive score ranging from 0-11.
Higher scores are consistent with greater endorsement of more cancer preventive behaviors. A
final question asks participants to identify reasons for not getting vaccinated.

Secondary measures
Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS; McRee, Brewer,
Reiter, Gottlieb, & Smith, 2010). The CHIAS is a 16-item self-report measure evaluating
beliefs and attitudes towards the HPV vaccine. Although the scale was developed and primarily
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used in studies with parent populations, the authors provide suggestions regarding scale revisions
for utilization with other populations (McRee et al, 2010). The scale contains questions that
assess four dimensions related to vaccine attitudes, including perceived harm (e.g., “The HPV
vaccine might cause lasting health problems”), barriers (e.g., “I am concerned the HPV vaccine
costs more than I can pay”), effectiveness (e.g., “How effective do you think the HPV vaccine is
in preventing genital warts”), and uncertainty (e.g., “I don’t have enough information about the
vaccine to decide whether to get it”). Twelve items are rated on a four-point scale from 1 to 4,
with unique anchor points (e.g., strongly disagree to strongly agree or slightly effective to
extremely effective) assigned to individual items. Four of the items are rated on a three-point
scale (i.e., not hard at all to very hard). Higher scores within each subscale are indicative of
stronger agreement, with summary scores ranging from 6-24 for the Perceived Harm subscale, 520 for Perceived Barriers, 2-8 for Perceive Effectiveness, and 3-12 for Perceived Uncertainty.
Internal consistency for each of the subscales is adequate (! = .61-.69) and consistent with what
was found in this study for the perceived harm and perceive barriers subscale (! = .73). Internal
consistency was very low for the Effectiveness and Uncertainty subscale (! = .42 and ! = .50,
respectively). Survey developers also reported a relationship between vaccination intentions and
each of the CHIAS subscales.
Data Analysis
SPSS version 20.0 was used to conduct all statistical analyses for this study. Prior to
data analysis, all of the data was screened for missing information and for violations of
normality. Although some of the data were not consistent with a normal distribution,
transformation of the scores did not influence study outcomes. Furthermore, transformation
techniques are no longer generally recommended, especially when the tests used are
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predominantly robust by design (Field, 2009). Accordingly, the remainder of analyses was
conducted on original data.
Descriptive statistics, including frequencies, means, and ranges, were performed to
describe the sample. Knowledge, motivation, and behavioral skills were assessed at baseline,
post-intervention and at one-month follow-up, and behavior change was assessed at the onemonth follow-up. Group equivalence on baseline IMB constructs was established using T tests
(continuous) and Chi squares (categorical); similarly, T tests and Chi square analyses were used
to test for mean differences on relevant baseline psychosocial factors. As recommended by Field
(2009), only baseline differences that are significantly correlated with each outcome of interest at
p < .05 were included as covariates for related tests. Baseline differences were discovered for
age and prior pap test history. In addition to these covariates, prior vaccination status was added
as a covariate across all statistical tests given its statistical and theoretical relationship with most
of the study outcomes. Similarly, insurance status was added as a covariate for tests of group
differences in behavioral skills given its potential impact on perceived obstacles and ability to get
vaccinated.
A series of 2X3 repeated measures analysis of covariance (ANCOVA) were used to
examine mean differences between groups on each of the composite factors of the IMB model:
1) knowledge, 2) motivation, and 3) behavioral skills. A multivariate analysis of covariance
(MANCOVA) was used to assess for group mean differences in the motivational construct given
the fact that the 5 scales used were highly correlated. This statistical test was used only for the
motivational index given the number of scales that comprise this factor, and studies suggest that
MANCOVA is helpful controlling for type 1 error and for accounting for the correlations among
these factors (Doherty & Graff Low, 2008). Post hoc independent sample T tests and/or pairwise
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T tests were used to further explore significant group differences at each of the time-points.
When post-hoc tests were conducted, the Family Wise Error Rate (FWE) was controlled for by
adjusting the significance level to p = .025 (i.e., .05/2 comparisons). Multivariate linear
regression analyses were used to determine significant predictors of vaccine acceptability.
Demographic variables theoretically and significantly associated with all of the IMB indices,
including age and prior HPV vaccination history, were entered into the regression analysis as one
block, and scales corresponding to each of the model’s constructs were entered together as a
second block. All statistical tests were two-tailed, and the significance level for all tests was set
at p < .05.
Results
Characteristics of the Sample
Table 1 details the demographic information for the whole sample. A total of 70 women
participated in the study. Of the 70 participants, 62 (89%) fully completed the one-month
follow-up survey. Two thirds of the sample were Caucasian, and about 21% self-identified as
Hispanic. Their mean age was 19 years (range, 18-26), and 75% were in their freshman (48.4%)
or sophomore (25.8%) year of college. About half of the respondents reported that they were
either employed part-time during the school year or over the summer, and the remainder of the
participants did not work. Family income was relatively high among respondents, with a little
over half reporting an income bracket greater than $75,000.
Health and health behaviors. Tables 2 and 3 provide general health information and
cervical cancer risk behaviors for the sample. The majority of the participants were insured
(92.9%), and they reported having a regular physician (87.1%). Approximately half of the
women perceived themselves to be very healthy; only 11.3% identified having a significant
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medical condition which consisted of a past cancer diagnosis (acute lymphoblastic leukemia),
Hepatitis C, Crohn’s Disease, chronic renal disease, and polycystic ovarian syndrome. More
than half of the women (59.7%) reported a positive familial history of cancer, but none reported
any personal or family history of cervical cancer. A large proportion of the sample engaged in
healthy lifestyle behaviors, with approximately 72.6% reporting regular exercising, 90.3%
denying any drug use, and only half (51.6%) engaging in some alcohol use. Specifically in terms
of cervical cancer screening behaviors, less than a third (27.4%) reported ever having had a pap
screen. Among the 17 women who have ever had a pap test, the majority (88.2%) initiated
screening when they were 16-19 years old and about 64.4% reported having been screened
within the past six months to one year.
Cervical cancer-specific behaviors and risk factors. The current sample was
predominantly sexually active (59.7%), with 1.6% first initiating sex as early as age 12, 34.4%
between the ages of 15-17, and 38.8% initiating sexual activity beyond age 18 (refer to table 3
for a summary of cervical cancer-specific behaviors). Among those who were sexually active, a
majority (64.9%) were in a monogamous, romantic relationship; a slightly larger proportion
(73%) reported having had only one sexual partner over the past year, and the remainder (21.6%)
reported having had more than 2 romantic partners. Only a small sample of women (8.1%)
reportedly had more than 5 sexual partners over the past year. The number of lifetime sexual
partners was slightly higher in this group; specifically, fewer than half indicated having only 1
lifetime sexual partner, 32.4% reported 2-4 lifetime sexual partners, and 21.6% identified as
having had more than 5 sexual partners in their lifetime. Despite their sexual history, the sample
predominantly engaged in safer sexual behaviors. About 75.6% of the women reported frequent
use of condoms, and only 8.1% and 10.8% reportedly using condoms “sometimes” or “rarely”,
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respectively. Accordingly, rates of sexually transmitted infections were low, with only 3.2%
identifying a history of Chlamydia infection. Similarly, few (4.8%) reported ever receiving an
abnormal pap test result. In terms of other behaviors associated with increased risk of cervical
cancer, few participants reported oral contraceptive use (22.6%) and fewer reported having ever
smoked (21%).
Awareness of HPV and Gardasil. Refer to table 4 for a summary of knowledge and
experience with HPV and Gardasil. The majority of the sample reported having heard about
HPV (87.1%), though few (8.1%) had actually undergone testing for HPV. Relatedly, a
considerable number of women reportedly had heard of the Gardasil vaccine (79%). Despite
their general awareness, nearly 77.4% of the sample considered themselves as having limited
knowledge about the vaccine, 17.7% admitting knowing nothing at all, and only 16.1% had
actually received at least one dose of the vaccine. The most popular medium through which
individuals first learned about the vaccine was via the television (50%), a friend (35.5%), and
through a non-PCP physician or nurse (33.9%). Few reportedly heard about the vaccine through
their PCP (27.4%), gynecologist (22.5%), and family (25.8%); however, a large proportion of the
sample (83.9) demonstrated a preference for learning about the vaccine from their primary care
doctor. Despite this preference, less than a quarter of the women were advised to get the vaccine
by their gynecologists, and only half (56.5%) received vaccine recommendations by their PCP.
Knowledge of HPV and Gardasil. Tables 5 and 6 provide a summary of women’s
knowledge of HPV and Gardasil. By and large, a majority of the women demonstrated a
considerable amount of knowledge of facts related to the Gardasil vaccine. Specifically, all of
the participants correctly believed that women who were vaccinated must continue to use
condoms during sex, and a large proportion correctly assumed that the vaccine does not protect
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against all STDs (96.8%). Similarly, the majority disagreed with the belief that vaccination
precludes individuals from requiring pap tests (98.4%) and reduces the need for regular pelvic
exams (91.9%). Notably, fewer women erroneously believed that women who get the vaccine
can worry less about getting STDs (83.7), and even fewer demonstrated an awareness that HPV
protects against cervical cancer (71%).
While general knowledge of Gardasil was high, women demonstrated poorer factual
knowledge of details related to HPV. Particularly, the participants in the study were most
misinformed about factors that increase risk for cervical cancer. Specifically, a very small
proportion of the sample recognized that smoking (12.9%) and oral contraceptives (4.8%)
increase risk for cervical cancer, and only 9.7% correctly believed that genital warts do not
increase risk for cervical cancer. Similarly, less than half of the sample knew that drugs (41.9%)
and diet (45.2%) is not related to cancer risk while having sex before 18 increases one’s
susceptibility for cervical cancer (45.2%). In addition, only 48.4% were aware that HPV
infection can remain latent without symptoms, and fewer (40.3%) correctly assumed that HPV
causes genital warts. Despite these general knowledge deficits, more women seemed to
understand the sexual nature of HPV. Specifically, a sizable proportion were aware that HPV is
sexually transmissible (75.2%) and that HPV is associated with cervical cancer (71.0%).
Accordingly, many believed that having multiple sexual partners (77.4%) and contracting any
sexually transmitted diseases (71.0%) can increase one’s risk for cervical cancer while tampon
use does not increase cancer risk (71.0%). In the same vein, approximately 74.2% of the women
correctly believed that celibacy, pap tests, and condom use are all effective methods for
preventing cervical cancer (74.2%).
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Intervention Effects on Information, Motivation, and Behavioral Skills
Information. A repeated measure ANCOVA was utilized to assess for group differences
in mean knowledge scores across all three time-points after adjusting for age, pap test
experience, and vaccination status. Mauchly’s Test of Sphericity was significant for the main
effect of time ("2 (2) = 8.438, p = .02) indicating that the assumption of sphericity was not met,
so a Greenhouse-Geisser correction was applied. A repeated measures ANCOVA indicated a
significant group by time effect for total HPV and Gardasil knowledge scores, F(1.76, 5.90) =
4.69, p = .015. This indicates that differences in total knowledge scores between conditions
depended on time. A polynomial contrast revealed a significant linear trend, F(1,57) = 8.38, p =
.005. To breakdown this interaction, a series of contrasts were performed comparing knowledge
scores for both conditions at each time-point. A simple effects contrast comparing knowledge
scores for each group at pretest and posttest revealed a marginally significant difference, F(1, 57)
= 3.984, p = .051. An examination of Figure 2 and adjusted group means shows that although
both conditions experienced an increase in knowledge scores from pre- to post test, there was a
greater increase in knowledge scores for participants in the experimental group compared to
participants in the control condition. Accordingly, post hoc t-tests suggests that knowledge
scores at posttest showed a marginally significant difference after controlling for the Familywise
Error Rate (p = .025), t(60) = -2.235, p = .029). Conversely, a second contrast measuring group
differences from posttest to follow-up yields no significant difference, F(1, 57) = .514, p = .476;
however, post hoc t-tests suggests that knowledge scores were significantly different at the onemonth follow-up, t(60) = -4.482, p < .001. A glance at Figure 2 and adjustment group means
suggests that although there were no significant changes in knowledge scores from posttest to
follow-up across conditions, women who participated in the experimental condition were likely
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to maintain a higher level of knowledge of HPV and Gardasil after one month; in contrast,
participants in the control condition demonstrated a nonsignificant decline in knowledge levels.
Additional repeated measures ANCOVAs were conducted for the individual measures
(i.e., total vaccine knowledge and knowledge of HPV and cervical cancer) used to arrive at the
total knowledge score. Mauchly’s Test of Sphericity was not significant for the main effect of
time ("2(2) = 3.953, p > .05) indicating that the assumption of sphericity was met. A repeated
measures ANCOVA for vaccine knowledge revealed a significant interaction effect, F(2, 114) =
3.876, p = .024. A polynomial contrast revealed a significant linear trend, F(1,57) = 6.74, p =
.012. Simple effects contrasts for pretest and posttest showed that vaccine knowledge increased
equally for both groups, F(1,57) = .000, p = .991; similarly, post-hoc t-tests showed there were
no significant group differences at the post-test, t(49.28) = 1.81, p = .076. Conversely, simple
effects contrasts for posttest and follow-up demonstrated a significant interaction at follow-up
F(1,57) = 4.589, p = .036. Specifically, while vaccine knowledge scores continued to increase at
follow-up for women in the experimental group, they decreased for participants in the control
condition. Closer examination of scores at follow-up via post hoc t-tests suggests the group
differences in vaccine knowledge were not significant, t(49.39) = -1.530, p = .132. Looking at
Figure 3, this suggests that vaccine knowledge significantly and steadily increased across timepoints for participants in the experimental group; in contrast, while vaccine knowledge increased
from pretest to posttest for the control condition, vaccine knowledge significantly decreased over
the follow-up period.
A third set of repeated measures ANCOVA was conducted for the measure of HPV and
cervical cancer knowledge. Mauchly’s Test of Sphericity was significant, "2(2) = 9.975, p =
.007, suggesting that the assumption of sphericity has been violated; as a result, a Greenhouse-
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Geisser adjustment was applied. Results of the repeated measures ANCOVA indicated a
significant group X time interaction for HPV and cervical cancer knowledge, F(1.72, 98.00) =
4.33, p = .02. A polynomial contrast revealed a significant linear trend, F(1,57) = 6.14, p = .016.
Closer examination of these results by looking at Figure 4 and simple effects analyses for pretest
and posttest knowledge scores suggest that participants in the experimental group showed more
pronounced increases in knowledge scores compared to the control group, F(1,57) = 4.93, p =
.03.

Post hoc t-tests showing significant group differences at posttest verified these results even

after controlling for the Familywise Error Rate, t(60) = -2.93, p = .005. A second simple effects
analysis demonstrates a similar increase in knowledge scores from posttest to the one-month
follow-up regardless of condition, F(1,57) = .00, p = .99; however, post-hoc t tests reveal
significant group differences at the follow-up, t(60) = -4.74, p < .001. Together, these results
suggest that compared to the control group, participants in the experimental group demonstrated
greater increases in knowledge of HPV and cervical cancer factual information at posttest, and
this level of knowledge was maintained through follow-up leading to sustained group
differences.
Motivation. Adjusting for age and vaccination status, a two-way, repeated measures
MANCOVA was conducted to determine the effect of condition on all 5 motivation constructs
across time. A significant group by time interaction was revealed, Pillai’s Trace (10, 47) = .509,
p < .001. Univariate ANCOVAs on each of the indices that compose the motivation construct
are reported as follow-up tests, and tests were appropriately adjusted with Greenhouse-Geisser
when Mauchly’s test of Sphericity was violated. Mauchley’s test of Sphericity was violated for
intent, "2(2) = 7.16, p = .03, attitudes, "2(2) = 7.18, p = .03, and perceived social norms, "2(2) =
22.35, p < .001. Significant group by time interactions were found for self-reported motivation,
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F(2, 112) = 4.16, p = .018, Intention, F(1.78, 99.82) = 7.40, p = .002, Attitudes, F(1.78, 99.79) =
7.11, p = .002, and perceived susceptibility, F(2, 112) = 3.126, p = .048. There was no
significant interaction or main effect of time or group for perceived social norms (p = .45).
Examination of Figure 5 in the context of simple contrasts comparing groups on self-reported
motivation revealed that the experimental group had a more pronounced increase in self-reported
motivation from pretest to posttest, F(1, 56) = 7.66, p = .008. On the other hand, a second
contrast of posttest and follow-up scores showed that each condition experienced a similar
decline in perceived motivation from posttest to follow-up, F(1,56) = .364, p = .548. Bonferroni
adjusted post hoc t-tests revealed no significant group differences in perceived motivation at
posttest, t(54.86) = -1.53, p = .131, or at follow-up t(60) = -.813, p =.42. As is evident in Figure
5, these results suggest that although both groups evidenced an increase and subsequent decrease
in motivation across all three time-points, the experimental group experienced a more
pronounced increase in self-reported motivation from baseline to follow-up; however, these
differences were not sustained at follow-up and instead declined along with the control group.
Figure 6 displays group changes in intention to get vaccinated across time-points. To break
down the interaction effect for self-reported intentions, a set of simple contrasts were performed
comparing both groups at each time-point. The first contrast looking at intention scores from
pretest to posttest revealed significant results, F(1,56) = 19.05, p <.001. Examination of Figure 6
and adjusted group means shows a more pronounced increase in intentions scores from pretest to
posttest for participants in the experimental group; accordingly, post hoc t-tests revealed
significant group differences in intentions to get vaccinated at posttest, t(51.11) = -2.23, p = .03.
A second contrast comparing groups across follow-up found that both groups experienced a
decrease in intentions from posttest to follow-up, but the decline was more pronounced for
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members of the experimental condition, F(1,56)=8.18, p = .008. Post hoc t-tests found no
significant group differences at follow-up (p = .807). These findings suggest that intentions
scores increased significantly for experimental participants immediately following the
intervention, however they declined just as quickly over the one-month period.
Similarly, the interaction effect for attitudes toward Gardasil vaccination was broken
down with a series of contrasts. Figure 7 displays change in attitudes toward Gardasil
vaccination across all three time-points. The first contrast investigated group differences in
attitudes between pretest and posttest. This contrast determined that the experimental group
displayed a more pronounced decrease in negative attitudes toward Gardasil vaccination, F(1,56)
= 19.41, p <.001. A significant group difference in attitudes at posttest was verified by
Bonferroni corrected post hoc t-tests, t(48.69) = 2.80, p = .007. Despite this decrease, a second
contrast determined that women in the experimental also experienced a pronounced increase in
negative attitudes from posttest to follow-up, F(1,56) = 5.63, p = .02. Post hoc analyses for the
follow-up showed no significant group differences in attitudes at this time-point, t(51.28) = .93,
p = .36. Together, these findings suggest that the experimental manipulation led to immediate
improvements in attitudes toward Gardasil vaccination following the intervention, however these
improvements were not sustained over one month. There were no significant changes in
attitudes for individuals in the control group.
Figure 8 displays changes in social norms related to getting vaccinated. Perceived social
norms for vaccination revealed no significant trends or group differences in scores across timepoints (p >.05). Inspection of Figure 8 shows that at first both groups experienced an increase in
social norms associated with getting vaccinated from pretest to posttest, and subsequently scores
declined at follow-up for both conditions. A look at the adjusted means suggests that the decline
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in perceived social norms was most prominent for participants in the control group, however this
difference was not significant.
Figure 9 displays changes in perceived risk for HPV and cervical cancer across time. The
first contrast examining group change from pretest to post test was nonsignificant, F(1,56) =
2.94, p = .092, suggesting that both groups experienced a similar increase in perceived risk
scores at the end of the experiment; however, adjusted group means suggests that the
experimental group experienced slightly increased risk perceptions following the manipulation.
Contrasts for the posttest to follow-up revealed a significant interaction effect, F(1,59) = 6.42, p
= .014. Bonferroni corrected post hoc t-tests revealed significant group differences only for the
posttest period, t(60) = -2.861, p = .006. As depicted in Figure 9, these results suggest that the
experimental group experienced an increase in HPV and cervical cancer susceptibility
immediately following the intervention, however this risk perception declined over the onemonth period. In contrast, there were no significant changes in perceived risk for HPV and
cervical cancer in the control group.
Behavioral skills. A two-way, repeated measures MANCOVA adjusting for age,
insurance status, and HPV vaccination status was conducted to determine the effect of condition
on both indices of behavioral skills, and no significant main or group interactions were detected
(p > .05). Despite these null results, univariate ANCOVAs were further examined to identify
any significance in the individual constructs. Tests were appropriately adjusted using
Greenhouse-Geisser when violations of sphericity occurred as indicated by Mauchley’s Test of
Sphericity. Analyses for perceived self-efficacy to get vaccinated revealed no significant main
or interaction effects (p > .05). Although not significant, a trend analysis was conducted to
examine potential trends in the data. Accordingly, a significant quadratic trend was found for the
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interaction effect, F(1,57) = 4.487, p = .039. This trend is displayed in Figure 10. Specifically,
perceived efficacy increased significantly from pretest to posttest for the experimental group, but
then it dropped significantly from posttest to follow-up. In contrast, scores for the control group
steadily increased across time. Post hoc analyses at each time-point revealed no significant
group differences posttest or at the one-month follow-up (p > .05). These findings suggests that
the IMB intervention may be more effective in increasing self-efficacy in the experimental group
in the short term, however these changes are not sustained over the one-month follow-up.
Univariate analyses for perceived difficulty were also examined. As indicated, tests were
appropriately adjusted using Greenhouse-Geisser when violations of sphericity occurred as
indicated by Mauchly’s Test of Sphericity. Similar to perceived self-efficacy, there were no
main or interaction effects for perceived difficulty (p>.05). In addition, there were no significant
trends in the data (p>.05). As indicated in Figure 11, ratings of perceived difficulty (or rather
feasibility) appeared to increase from pretest to posttest regardless of condition; however, ratings
decreased from posttest to follow-up for both groups. Examination of adjusted means in
conjunction with Figure 11 suggests that the experimental group experienced a more pronounced
increase in perceived feasibility to get vaccinated from pretest to posttest; however, these beliefs
declined to baseline rates by the one-month follow-up. These changes were not significant.
Behavioral Intentions. There was a significant association between group and
intentions to get vaccinated "2 (2) = 6.88, p = .032. This suggests that participants in the
experimental group were more likely to report wanting to get vaccinated at the one-month
follow-up compared to participants who participated in the control group. Based on the odds
ratio, the odds of wanting to get vaccinated were 7.69 times higher if women participated in the
experimental group compared to the control group. In addition, intentions to engage in
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additional behaviors related to getting vaccinated demonstrated a significant relationship with
group status, "2 (1) = 6.61, p = .01. Women in the experimental group were 6.90 times more
likely to report intentions to engage in vaccination-seeking behaviors compared to women in the
control condition. Lastly, there was a significant relationship between group status and
intentions to get pap smears in the future "2 (2) = 15.84, p = .003. Based on the cross-tabulation
table, women who participated in the experimental group were more 26.13 times more likely to
anticipate getting a pap screen every two years, as recommended by CDC (2012); conversely,
women in the control group were 4.93 times more likely to anticipate getting yearly pap tests.
There were no group differences in intentions to get vaccinated, get pap smears, or engage in
vaccine-seeking behaviors at baseline and the one-month follow-up (p>.05).

Cervical Cancer Preventive Behaviors
Mean differences in the aggregate set of behaviors associated with cancer prevention
were examined with independent t-tests. There were no significant differences between groups
in terms of behaviors performed at baseline, t(60) = .000, p = 1.00, and at the one-month followup, t(60) = -.140, p = .89. However, mean differences in behaviors within groups were examined
at baseline and follow-up using paired-sampled t-tests. On average, women who participated in
the experimental group endorsed more cancer prevention behaviors at follow-up (M = 2.87, SE =
.29) compared to baseline (M = 2.19, SE = .24). This difference was significant t(30) = -2.39, p
= .023, and it represents a medium-sized effect r = .38. Conversely, women who participated in
the control group did not demonstrate a difference in cancer preventive behaviors from baseline
(M = 2.19, SE = .17) to follow-up (M = 2.81, SE = .36), t(30) = -1.84, p = .076. These results
suggest that women in the experimental group demonstrated a significant, positive change in
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cancer prevention behaviors as compared to women in the control condition, although at followup the differences between the two groups were not significant.
Group differences for each of the individual behaviors associated with cancer prevention
were examined with contingency tables using Chi Square tests. There were no significant
differences between groups at baseline or at the one-month follow-up for behaviors related to
accessing more information about Gardasil, discussing Gardasil with family, friends, or doctor,
scheduling an appointment to begin the HPV vaccination series, initiating the vaccine series,
condom use, scheduling a pap smear, or getting a pap test (p > .05).
Predictors of cervical cancer preventive behaviors
A hierarchical multiple regression analysis was conducted to evaluate how well the IMB
theoretical model predicts overall cervical cancer preventive behaviors after adjusting for age
and vaccination status. Table 7 shows a summary of the regression analysis. At step 1, none of
the demographic variables were significantly associated with preventive behaviors; however,
adding each of the IMB indices to the second step resulted in a significant F change statistic,
F(8,51) = 6.43, p < .001. Accordingly, the IMB model accounts for 50% of the variance in
cancer preventive behaviors,

R2 = .50, R2 = .50, adjusted R2 = .41, and the overall regression

equation is statistically significant (F[10, 51] = 5.17, p < .001). Close examination of the
individual variables suggests that not all variables are equally important in this model. In fact,
perceived susceptibility (b = -.10, B = -.31, p = .011) and prior vaccination initiation (b = -1.79,
B = -.37, p = .005) had a statistically significant effect on preventive behaviors. These findings
suggest that each one standard deviation increase in perceived susceptibility led to a .31SD
decrease in cancer preventive behaviors. Similarly, each standard deviation increase in prior
vaccination status led to a .37SD decrease in cancer preventive behaviors.
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Secondary Analyses
Attitudes toward vaccination. Adjusting for age and vaccination status, a series of two
way, repeated measure ANOVAs were conducted to examine group differences in each of the
four dimensions of general attitudes toward the HPV vaccine as measured by the CHIAS. Tests
were appropriately adjusted with Greenhouse-Geisser when Mauchly’s test of Sphericity was
violated. Mauchley’s test of Sphericity was violated for perceived harm, "2(2) = 6.86, p = .03
only, and analyses investigating group differences in perceived vaccine harm across time-points
found a significant interaction effect, F(1.80, 104.18) = 9.37, p <.001. Contrasts conducted to
further delineate group differences determined that the experimental group displayed a
prominent decrease in perceived vaccine harm from pretest to posttest, F(1,58) = 20.25, p < .001;
however, ratings did not significantly change from posttest to follow-up for either condition,
F(1,58) = .171, p = .68. Accordingly, Figure 12 shows that for the control group, perceived harm
associated with getting vaccinated remained relatively stable across time-points. In contrast,
perceived harm decreased significantly immediately following the intervention for participants in
the experimental group, and these differences were maintained at the one-month follow-up.
Figure 13 shows changes in ratings of perceived barriers to getting vaccinated across time-points,
and a two way repeated measures ANOVA revealed no significant main effects for time, group,
or the interaction as well as no significant trends. As depicted in Figure 13, perceived vaccine
barriers declined for both conditions immediately following the experiment, and they increased
slightly for both groups at the one-month follow-up. A third ANOVA conducted on perceived
efficacy of vaccination found a significant interaction effect, F(2,116) = 5.20, p = .007. Followup contrasts revealed a difference between groups immediately following the experiment,
F(1,58) = 10.98, p = .002, but not at the follow-up, F(1,58) = 1.16, p = .286. Bonferroni adjusted
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t-tests verifies these findings by highlighting significant group differences at posttest, t(59.36) = 2.308, p = .024. Accordingly, Figure 14 illustrates the pronounced increase in perceived vaccine
efficacy scores for the experimental group compared to the control following the intervention. It
also shows the decline in efficacy scores that occurred for both groups after one month. Lastly, a
repeated measures ANOVA conducted for perceived uncertainty related to Gardasil found no
significant interaction effects, main effects for time or group, or trends (p>.05). Bonferroni
corrected post hoc t –tests revealed group differences at posttest that approached significance, t
(59.45) = 2.064, p =.043. As indicated in Figure 15, the IMB demonstrated more pronounced
decreases in ratings of uncertainty from pretest to posttest, however ratings slightly increased at
the one month follow-up; conversely, ratings of uncertainty steadily decreased across all three
time periods for the attention control group.
Perceived severity of cervical cancer. A two way, repeated measures ANCOVAs was
conducted to examine group differences in perceived seriousness of HPV and cervical cancer. A
significant interaction effect was found after controlling for sexual and vaccination status, F(2,
116) = 4.353, p = .015. Follow-up simple effects contrasts revealed a significant interaction
effect only from pretest to posttest, F(1,59) = 10.13, p = .002. Similarly, Bonferroni corrected
post hoc t-tests revealed significant group differences at the posttest period only, t(60) = 2.917, p
= .005. As depicted in Figure 16, these results suggest that women in the experimental group
experienced a significant decline in perceived severity scores immediately following the
intervention, and perceptions of diagnostic severity only slightly increased over the one-month
period. In contrast, women in the control showed the opposite pattern; specifically, women in
the control arm experienced a significant increase in perceived severity scores immediately
following the study, and they experienced a subtle decrease in scores over the one-month period.
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Discussion
The main purpose of this study was to examine the effectiveness of a theory-based,
single-session, educational program to promote Gardasil use among undergraduate women
enrolled at the University of Connecticut. Study findings related to vaccine, cervical cancer, and
HPV knowledge were consistent with what has been reported in the literature (Daley, Perrin,
McDermott, Vamos, Rayko, & Packing-Ebuen, 2011; Gerend & Shepherd, 2011). Specifically,
this sample of undergraduate women demonstrated high levels of vaccine knowledge but in the
context of lower mastery of HPV and cervical cancer information. Following the experiment, as
hypothesized the intervention condition was overall more effective in increasing vaccine, HPV,
and cervical cancer knowledge when compared to an attention control group. Specifically, this
theory based educational approach was successful in improving women’s knowledge of Gardasil,
HPV, and cervical cancer risk above and beyond that which can be attained through popular
mediums readily available to the public. In addition, it enhanced the likelihood that this
information was maintained after one month. Initial examination of the data shows that both the
intervention and control group evidenced an increase in total knowledge scores across all 3 timepoints, suggesting that the experimental manipulation failed to engender substantial changes in
knowledge scores. Closer inspection of HPV and vaccine specific knowledge independently
suggests that this effect is more likely an artifact of the components of the control arm.
Specifically, participants in the control condition were given a standard Gardasil information
sheet that imparted general information about the Gardasil vaccine. Although few studies have
explored the use of educational pamphlets to enhance HPV vaccine-specific knowledge in high
risk populations, the use of informative flyers and pamphlets have led to notable increases in
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vaccine knowledge (Gotvall, Tyden, Hoglund, & Larsson, 2010; Kennedy, Sapsis, Stokley,
Curtis, & Gust, 2011). In addition to getting vaccine-specific information, the educational
videos used for the control group also communicated brief but general information about
vaccination and HPV as these are topics commonly related to women’s health. Nonetheless,
despite these similarities, participants in the experimental group evidenced more pronounced
increases in HPV and cervical cancer-specific knowledge that were maintained at the one-month
follow-up.

Moreover, although both conditions demonstrated parallel increases in vaccine-

specific knowledge immediately following the manipulation, only the experimental group
retained this knowledge base at the follow-up. These findings are important and consistent with
other studies that report similar improvements in cervical cancer risk, STD, and HPV-specific
knowledge in response to a variety of educational approaches (Doherty & Graff Low, 2008;
Gotvall et al, 2010; Jaworski & Carey, 2001; Warren, 2010). Of particular import is the finding
that the experimental manipulation led to sustained increases in vaccine specific knowledge
despite similar exposure to vaccine-specific information across conditions, suggesting that
participants in the experimental group derived additional benefits from the intervention. It is
possible that the provision of vaccine information alone without supplemental information
highlighting the relationship between HPV, cervical cancer, and Gardasil makes it less likely that
women will view the information as important and relevant. In fact, HPV and cervical cancer
risk perception was magnified immediately following the intervention for women in the
experimental group alone. Accordingly, individuals who do not find the information to be
personal and relevant may be less likely to process and review the information over time
(Shavitt, Vargas & Lowrey, 2004). Secondly, the use of pamphlets or flyers alone may not be a
sufficient medium for this information, as not everyone is invested in reading informational
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sheets (Warren, 2010) or is capable of understanding the information (Waller, Marlow, &
Wardle, 2007). In fact, studies in the marketing literature indicate that individuals who are
interested in materials presented are more likely to be more attentive and to recall the
information presented (Shavitt et al, 2004). Nonetheless, in the context of low to moderate levels
of HPV knowledge reported for this high risk population (Daley et al, 2011; Gerend & Shepherd,
2011; Sandfort & Pleasant, 2009), these findings have important implications for cancer risk
reduction, especially given the research linking knowledge of HPV and Gardasil to intentions to
get vaccinated (Jones & Cook, 2008; Wong & Sam, 2007).
Unlike the notable improvements in knowledge scores, our theory that the intervention
will enhance motivation to get vaccinated against HPV was partly supported. Specifically,
participants in the experimental condition demonstrated a significant change in four of the five
indices of motivation targeted by the intervention: self-reported motivation, intentions, attitudes
toward vaccination, and perceived risk for HPV and cervical cancer. These findings corroborate
existing studies that have demonstrated similar shifts in some dimensions of motivation,
specifically intentions and attitudes, following didactic strategies targeting Gardasil uptake (Cox
et al, 2010; Doherty & Graff Low, 2008; Kennedy et al, 2011; Kepka, Coronado, Rodriguez,
Thompson, 2012; Kwan, Tam, Lee, Chan, & Ngan, 2011; Patel et al, 2012). For instance,
Doherty and Graff Low (2008) determined that a web-based, self administered educational
intervention was successful in generating significant improvements in knowledge and attitudes to
HPV vaccination in a sample of mixed gendered college students. Similarly, Patel et al (2012)
reported high levels of intention and vaccine uptake six months post intervention in
undergraduate women exposed to an HPV informational session compared to standard of care.
Regarding our finding of improvements in self-rated motivation, there are no known studies to
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date that attempt to alter perceptions of motivation to get vaccinated through health behavior
interventions. The paucity of studies that focus on generating motivational shifts is notable
given the strong link between motivation and behavior change (Kalichman et al, 2008).
Notwithstanding, the study’s focus on integrating evidence-based motivational strategies to
enhance intrinsic motivation justifies the upward trend in members of the IMB group.
Interestingly, improvement in these four indices ceased post-intervention, demonstrating a
decrease in scores over the one-month follow-up. Although unexpected, it may be that more
than one intervention session is necessary to provoke enduring shifts in motivation.
Nonetheless, in the context of low levels of motivation initially observed in this sample, these
findings are important as the IMB model stresses the importance of motivation in inciting
positive behavior change even amongst well-informed individuals (Fisher & Fisher, 2000).
Contrary to our hypothesis, the intervention was no more effective than an attention
control group in engendering changes in social acceptability of Gardasil. In fact, perceived
social norms to getting vaccinated increased uniformly across both conditions immediately
following the manipulation. This outcome was surprising given the study’s emphasis on destigmatizing HPV infection and vaccination behaviors by delivering risk and preventive
information in a group setting; however, it remains in line with findings from other IMB driven
interventions wherein perceived social norms for safe-sex behavior demonstrate resistance to
change (Fisher et al, 1996; Jaworski & Carey, 2001). This pattern of results may be explained by
the fact that health education was delivered in a group format for both conditions, thereby
normalizing all women health topics regardless of subject matter or magnitude of coverage.
Although the control group received limited information about HPV and Gardasil, it is plausible
that discussing general themes associated with women’s health in a peer setting is sufficient to
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modify perceived social norms for a myriad of health behaviors, including vaccine-seeking
behaviors; however, this does not explain why the intervention did not elicit greater
improvements in perceived vaccine acceptability given its focus on Gardasil. More likely is the
possibility that the questionnaire items used to assess for social norms tap into an aspect of social
acceptability that is not attended to by the intervention (Fisher et al, 1996). Specifically,
questionnaire items inquire about the perceptions of people most important to participants though
these individuals were not involved in the study itself. Based on prior experiences with
important family members, friends, and physicians, women in the intervention condition may not
be convinced that others important to them will approve of the vaccine (Fisher et al, 1996).
Indeed, studies show that parental approval and physician support are amongst the strongest
indicators of vaccine behaviors (Bynum, Malo, Lee, Guillano, & Vadaparampil, 2011; Etter et al,
2012; Grantham, Ahern, & Connolly-Ahern, 2011; Hollander, 2012; Hopfer, 2012; Malo,
Hassani, Staras, Shenkman, Guiliano, & Vadaparampil, 2012; Rosenthal et al, 2011).
Appropriately, many of the women in the study voiced an interest in pursuing Gardasil but were
less likely to get vaccinated because their parents did not condone the vaccine and their
physicians did not recommend it. This evidence is disconcerting, as physicians have
demonstrated reluctance towards discussing the vaccine with their patients as a result of time
constraints, lack of initiation on behalf of the patient, negative perceptions of the vaccine, and
perceived parental concerns (Etter et al, 2012; Malo et al, 2012; Quinn, Murphy, Malo, Christie,
& Vadaparampil, 2012). Accordingly, future research in this area may benefit from including
important individuals, such as parents, in these group-based approaches in efforts to normalize
HPV vaccination. It is important to point out that, though nonsignificant, perceived social norms
exhibited a steep decline for the control group while they remained relatively stable across time-
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points for the IMB group. This is worthy of mention, as it suggests that the intervention may
have exerted a change in social norms across time for the IMB group. It is possible that
discussion of Gardasil in a larger group context may have contributed to perceived peer
acceptance, and this may be what is sustained across time-points; however, a larger sample size
may be necessary to detect this subtle, but important, change (O’Grady et al, 2009).
The IMB model contends that even well intentioned and knowledgeable individuals
require a set of skills to enable them to execute a health behavior (Fisher & Fisher, 2000).
Behavioral skills are conceptualized as consisting of both objective and perceived (i.e., selfefficacy) means of performing the behavior. At pretest, both groups of women did not appear to
have any thoughts regarding their beliefs in their ability to get vaccinated nor the level of effort
involved, suggesting that these women may not have truly considered the steps one would take to
get vaccinated. Following the manipulation, both groups evidenced an initial increase and
subsequent decease in perceived ability to overcome obstacles to getting vaccinated. Also
contrary to our prediction, the intervention did not elicit higher levels of perceived efficacy
scores when compared to the control group. Though surprising, this outcome is consistent with
other studies that have employed brief interventions to guide skill acquisition (Jaworski & Carey,
2001; O’Grady et al, 2009). In fact, successful improvements in self-efficacy and perceived ease
with engaging in target behaviors have been demonstrated in studies with lengthier intervention
approaches that were delivered over a span of 3-5 days (Fisher et al, 1996; Fisher et al, 2002;
Singh, 2003). While there are other plausible factors that can explain this relationship, it is
possible that these women did not have the opportunity to practice the skills they learned in
session thereby leading to limited changes in perceived effectiveness and feasibility relative to
the control group (Jaworski & Carey, 2001). This improvement may also reflect the importance

42

of integrating expert opinion and peer support into messages promoting HPV vaccination, which
was unaddressed in this study as noted by the lack of change in perceived norms. Accordingly,
one study founded on culture-centric narrative theory (Hopfer, 2012) determined that, relative to
peer-led and expert-led narratives, a 4 minute narrative that combined both expert- and peer
influence was most successful in enhancing vaccination self-efficacy (Hopfer, 2012). This
finding also makes sense given the IMB model’s premise that information and motivation are
both essential in the process of skill acquisition, especially for more complex health behaviors
(Fisher & Fisher, 2000).
As hypothesized, women who participated in the experimental arm reported significantly
stronger intentions to get vaccinated in comparison to women in the control condition.
Moreover, these women also exhibited overall greater intentions to engage in other behaviors
associated with getting vaccinated, including procuring more vaccine-specific information and
conversing with friends about the vaccine. These findings are worthy of attention, as studies
have identified a strong relationship between intentions and actual vaccination behaviors (Patel
et al, 2012). Nonetheless, a considerable number of barriers, including lack of physician and
parental support, persist and likely contribute to the low vaccination rates widely reported in the
literature (Patel et al, 2012). Accordingly, these findings underscore the importance of
identifying and addressing these barriers in future interventions.
Of equal import to the broader mission of cervical cancer prevention is the finding that
the experimental group displayed greater intentions to comply with current screening standards.
Recently, guidelines regarding cervical cancer screening underwent a fortuitous change,
discouraging women from getting tested prior to age 21 and then only recommending screening
every three years through age 30 (CDC, 2012). Experts argue these changes are beneficial given
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the fact that pap tests are limited in sensitivity and specificity and are therefore often
unsuccessful in detecting a disease that takes years to progress (ACS, 2012; Patel et al, 2012).
Furthermore frequent false positives incite anxiety in women undergoing testing and lead to
unnecessary, prophylactic treatments (Patel et al, 2012). Accordingly, our finding that women in
the control condition are more likely to engage in frequent screening suggests they may be more
susceptible to elevated distress in the context of limited benefits. In addition, it is possible that
women who are uninformed about HPV and cervical cancer may interpret changes in screening
practices as an indication that screening is not important. This raises concern, as there is existing
research verifying underutilization of pap testing among young adult (Charlton, Corliss,
Missmer, Frazier, Rosario, Kahn et al, 2011). Given this evidence, the absence of screening
behavior in the context of elevated risk suggests that vaccination is an even more valuable tool
affording greater risk reduction.
Contrary to our hypothesis, women exposed to the IMB intervention did not engage in
more preventive behaviors, including risky sexual practices, increasing regular pap smears, and
taking steps to get vaccinated, in comparison to the attention control group. In regards to our
first outcome of interest, vaccine uptake, there were no group differences in Gardasil acquisition
at the one-month follow-up. While this outcome may be discouraging, it is reasonable given the
short follow-up period. In fact, the one study that explored the impact of an educational
intervention on vaccine uptake in college students found no influence in vaccine uptake at 6
months despite the inclusion of a reminder letter (Patel et al, 2012). It is possible that participants
may be actively interested in getting vaccinated, however physical barriers such as distance from
their gynecologist or PCP may render them unable to get vaccinated. Although participants can
seek vaccine information and procure the vaccine from other clinics, they may prefer speaking
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about the vaccine with familiar physicians (Cermak, Cottrell, & Murnam, 2010; Hopfer, 2012;
Krawcyk et al, 2012; Rosenthal et al, 2011). It may also be that a longer follow-up time-point is
needed to detect changes in vaccine uptake in this high-risk population. Lack of access and
infrequent visits to their physicians may also explain why there were no significant differences
between conditions for behaviors related to completing pap screens. Furthermore, other work or
school conflicts may be prioritized and therefore pose an obstacle to scheduling. Nonetheless, an
important discovery in Patel and colleagues (2012) study is their conclusion that vaccine
intentions were related to vaccine uptake at the follow-up period, suggesting that an extended
follow-up may help accentuate actual improvements in vaccine uptake. This evidence is
encouraging in light of our finding of significant improvements in cervical cancer behaviors for
women in the experimental condition alone when within group differences across time were
examined separately; in contrast, women in the control condition did not show any significant
improvements in cancer preventive behaviors.
It is unclear why the experimental manipulation did not elicit more conversation about
HPV or Gardasil with family or friends, however this null finding may be attributed to the fact
that families were not incorporated into the active intervention. As aforementioned, parental
support is central to young women’s decision to get vaccinated (Bartlett & Peterson, 2011); it
may be that participants are not comfortable broaching discussion of Gardasil and HPV with
their parents by phone, especially if prior experience suggests parental disapproval. Lastly, the
lack of group differences in condom use at the one-month follow-up is consistent with studies
that report limited improvements in sexual health behaviors following brief risk-reduction
interventions (Gotvall et al, 2010; Jaworski & Carey, 2001). In fact, a similar study by Jaworski
and Carey (2001) exploring the efficacy of a brief, one session intervention aimed at reducing
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STD risk in an undergraduate female population found no improvements in condom use at the
two month follow-up. These authors suspect that women may hesitate broaching the subject of
condom use while in committed relationships (Jaworski & Carey, 2001). Indeed, studies that
have employed multi-session approaches have had more success in engendering changes in
condom use behaviors and number of sexual partners (Fisher et al, 2002). These reports further
substantiate our speculation that longer interventions and follow-up periods may be necessary to
elicit and detect subtle changes in more complex health behaviors.
Lastly, our final hypothesis regarding the predictive capacity of the IMB model was not
supported. In its totality, all three of the components of the IMB model appear to be effective in
predicting greater performance of preventive behaviors at the one-month follow-up, however not
all of its elements were equally important. Specifically, our findings indicate that only two
factors, primarily perceived risk for HPV and cervical cancer as well as prior solicitation of
Gardasil, drive this relationship. Even more interesting is our finding that higher scores in these
two factors yielded less likelihood of engaging in cervical cancer preventive behaviors. The role
of perceived risk in stimulating health behavior change has been widely explored in the literature
through a variety of theoretical models and intervention approaches (Cracium, Schuz, Lippke, &
Schwarzer, 2010; Schwarzer & Luszczynska, 2011; Weinstein, Lyon, Sandman, & Cuite, 1998)
and reports remain inconsistent. Some findings suggest that perceived risk of negative health
consequences stimulates health behavior practice and reduction of risky sexual behaviors
(Brewer, Weinstein, Cuite, Herrington, 2004; Lerman, Schwartz, Lin, Hughes, Narod, & Lynch,
1997). Conversely, other studies suggest that elevated levels of perceived risk can actually
dissuade individuals from behavior change (Brewer et al, 2004; Wusu, 2011). It is unclear why
perceived risk played a large role in predicting cervical cancer screening behaviors in this study,
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but this outcome is more likely an artifact of the small sample size. Similarly, our finding that
HPV vaccination history predicted fewer preventive behaviors is more likely due to the
possibility that women who have already completed 1 of the 3 vaccine series may have been less
inclined to engage in discussions with family or friends about the vaccine.
Despite the novelty of these findings, this study has several limitations. Because this
study recruited women from a convenience sample, the study findings are limited in
generalizability and may not reflect the opinions of women beyond this particular sample.
Importantly, these women were predominantly Caucasian, heterosexual, insured women enrolled
in a local university. Prior research has illustrated limited knowledge of HPV and
underutilization of Gardasil among uninsured, low SES, minority and homosexual women (Cook
et al, 2010; McCave, 2010; Niccolai et al, 2011; Liddon et al, 2012; Mcnair, Power, and Carr,
2009), thus future studies should examine these attitudes among ethnic and sexually diverse
groups as well as those who are lower in SES. Similarly, future studies should be undertaken
with men now that Gardasil recommendations have been extended to this group; vaccination of
men can help further reduce transmission of HPV infection. In addition to these psychosocial
limitations, this study has some methodological shortcomings. Firstly, the small sample size
may have contributed to limited findings as some analyses were not sufficiently powered to
detect small effects. It is possible that a larger sample size may be necessary to detect even the
most subtle behavioral changes, such as those related to vaccine receipt. It is often difficult for
women to schedule meetings with their physicians to discuss or pursue vaccination, as their
college may be several states away from home and their doctors. Accordingly, despite good
intentions, physical and academic obstacles may be realistic impediments to scheduling proximal
doctor visits. Accordingly, studies that follow women longitudinally are better equipped to
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ascertain these behavioral effects (Patel et al, 2012).

A similar point, this intervention was

delivered over a brief, one session visit. An overwhelming majority of studies employing the
IMB model deliver the intervention over a span of several sessions, and their findings often
document successful intervention effects on health behaviors (O’Grady et al, 2009; Fisher et al,
2002). Nonetheless, while this can be considered a drawback, the development of brief
programs to enhance cervical cancer preventive behaviors is warranted given the time
limitations, the need for practical, generalizable programs, and the import of capturing the
attention of this high risk population (Moore, Smith, & Folsom, 2012).
The group structure and format posed some additional limitations to this study. Firstly, a
systematic defect in the recruitment method led to large variability in group size and to the
participation of women who identified as having completed the vaccine series. Although
statistically accounted for, differences in group size and composition can influence the diversity
of viewpoints and topics presented during group discussion. Nevertheless, in light of the broader
picture, this problem is trivial given the fact that real-life application of this cancer prevention
program will be carried out with a large, diverse body of undergraduate students, regardless of
ethnicity, race, and/or vaccination status. Moreover, given the evidence linking parental
influence to vaccine uptake, future endeavors should consider ways to include both parents and
undergraduate students within group interventions. Also related to group structure and overall
study design, future research designs should consider including a third control group that more
closely resembles true standard of care, such as the Gardasil pamphlet that is readily available in
clinic offices. Efforts to maintain group equivalence in this study may have led to the inclusion
of elements that generated improvements in the IMB indices for members of the control group,
thereby obfuscating group differences that would otherwise be larger (Patel et al, 2012).
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Lastly, there were some theoretically based limitations that could have influenced study
results. First, the scales used in this study were not all validated, as they were created and
modeled after scales used in other studies based on Fisher and Fishers’ IMB model (Fisher et al,
1996; Fisher et al, 2002). As a result, alpha coefficients were low for some measures, although
Cohen and Cohen (1983) argue that this would only reduce the effect of the intervention (as cited
in Fisher, Fisher, Bryan, & Misovich, 2002). In addition, to remain consistent with Fisher and
Fisher’s (1992) model, future endeavors should utilize structural equation modeling (SEM) to
confirm the model’s ability to predict vaccine uptake. Furthermore, interventions based on the
IMB model call for elicitation research prior to intervention development. Although time
limitations precluded us from adhering to these guidelines, it is important to note this
intervention was still able to generate significant knowledge gains in women participating in the
IMB program. Lastly, the development of generalizable interventions requires an iterative
process whereby effective components are modified and improved on based on study outcomes
and participant feedback. Qualitative data in the form of exit interviews would be a valuable
supplement to future studies investigating the efficacy of this program, as they can help elucidate
the feasibility and acceptability of the program prior to the coordination of larger scale studies.
In spite of these limitations, this study is one of the first to examine the influence of a
theoretically based model in effecting changes in vaccine uptake as well as other health
behaviors related to cervical cancer prevention among a high risk population. The findings in
this study are consistent with current research that suggest young women are generally aware of
Gardasil, are less informed about HPV and cervical cancer, and are ambivalent about pursuing
vaccination against HPV. Furthermore, our findings indicate that the IMB model may accurately
represent factors that play into young women’s decision to vaccinate against HPV, a highly
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prevalent STD in this population. Moreover, an IMB-based intervention may also provide
universities with a powerful strategy to impel women to get vaccinated and also engage in
ancillary, premptive behaviors, including sexual risk practices. Recent changes in screening
guidelines have shifted pap test initiation to occur during a time when students are graduating or
in the midst of finding a job; as a result, they may experience changes or lapses in insurance
coverage. This is disconcerting, given some evidence that suggests HPV infections are less
likely to clear with age (Harper et al, 2008). Under these circumstances, the development of
programs that motivate women to get vaccinated is becoming even more vital to our movement
towards cancer prevention. This intervention is a step forward in providing universities with an
inexpensive, brief and effective program that can be easily integrated and delivered to students
and their families during school-wide orientation periods. Therefore, future emphasis should be
placed on validating the theoretical model and further examining its ability to incite vaccination
behaviors in this at risk population.

50

References
Allen, J.D., Mohllajee, A.P., Shelton, R.C., Othus, M.K.D., Fontenot, H.B., & Hanna, R. (2009).
Stage of adoption of the human papillomavirus vaccine among college women.
Preventive Medicine, 48, 420-425.
American Cancer Society website. Cervical Cancer: Causes, Risk Factors, and Prevention
Topics. Available at http://www.cancer.org/cancer/cervicalcancer/detailedguide/cervicalcancer-risk-factors. Accessed May 1, 2012.
American College of Obstetricians and Gynecologists [ACOG] (2010). Human Papillomavirus
vaccination. Committee Opinion, NO. 467. Obstetrics & Gynecology, 116, 800-803.
Bartlett, J.A. & Peterson, J. (2011). The uptake of HPV vaccine among females in the US; A
review of the literature. The Journal of School Nursing, 27, 434-446.
Bendik, M.K., Mayo, R.M., Parker, V.G. (2011). Knowledge, Perceptions, and Motivations
Related to HPV Vaccination Among College Women. Journal of Cancer Education.
[Epub ahead of print].
Brewer, N.T., Weinstein, N.D., Cuite, C.L., & Herrington, J.E. (2004). Risk Perceptions and
Their Relation to Risk Behavior. Annals of Behavioral Medicine, 27, 125-130.
Briones, R., Nan, X., Madden, K., & Waks, L. (2012). When vaccines go viral: An analysis of
HPV vaccine coverage on YouTube. Health Communication, 27, 478-485.
Bynum, S.A., Malo, T.L., Lee, J.H., Guillano, A.R., & Vadaparampil, S.T. (2011). HPV vaccine
information-seeking behaviors among U.S. physicians: government, media, or
colleagues? Vaccine, 29, 5090-5093.
Carey, M. P., Braaten, L.S., Maisto, S.A., Gleason, J.R., Forsyth, A.D., Durant, L.E. et al.
(2000). Using information, motivational enhancement, and skills training to reduce the

51

risk of HIV infection for low-income urban women: A second randomized clinical trial.
Health Psychology, 19, 3-11.
Caskey, R., Lindau, S.T., & Alexander, G.C. (2009). Knowledge and early adoption of the HPV
vaccine among girls and young women: Results of a national survey. Jouranl of
Adolescent Health, 45, 453-462.
Center for Disease Control and Prevention (2011a). Genital HPV Infection - Fact Sheet. Atlanta,
GA: US Department of Health and Human Services. Center for Disease Control and
Prevention, 2011. Retrieved May 4, 2011 from http://www.cdc.gov/std/hpv/stdfacthpv.htm
Center for Disease Control and Prevention (2011b). National Survey shows HPV vaccine rates
trail other teen vaccines: Poor and minority teens less likely to finish the three dose HPV
vaccine series. Atlanta, GA: US Department of Health and Human Services. Center for
Disease Control and Prevention, 2011. Retrieved August 13, 2012 from
http://www.cdc.gov/media/releases/2011/p0825_hpv_vaccine.html.
Center for Disease Control and Prevention (2012). Cervical Cancer Screening Guidelines for
Average-Risk Women. Center for Disease Control and Prevention, 2012. Retrieved
October 4, 2012 from http://www.cdc.gov/cancer/cervical/pdf/guidelines.pdf.
Cermak, M., Cottrelll, R., & Murnan, J. (2010). Women’s knowledge of HPV and their
perceptions of physician educational efforts regarding HPV and cervical cancer. Journal
of Community Health, 35, 229-234.
Charlton, B.M., Corliss, H.L., Missmer, S.A., Frazier, A.L., Rosario, M., Kahn, J.A., et al.
(2011). Reproductive Health Screening Disparities and Sexual orientation in a cohort

52

study of U.S. Adolescent and Young Adult Females. Journal of Adolescent Health, 49,
505-510.
Collins, Y., Einstein, M.H., Gostout, B.S., Herzog, T.J., Massad, S., Rader, J.S., et al. (2006).
Cervical cancer prevention in the era of prophylactic vaccines: A preview for
gynecologic oncologists. Gynecologic Oncology, 102, 552-562.
Conroy, K., Rosenthal, S.L., Zimet, G.D., Jin, Y., Berstein, D.I., Glynn, S. et al. (2009). HPV
vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination.
Journal of Women’s Health, 18, 1679-1686.
Cook, R.L., Zhang, J., Mullins, J., Kauf, T., Brumback, B., Steingraber, H. et al. (2010). Factors
associated with initiation and completion of HPV vaccine series among young women
enrolled in medicaid. Adolescent Health Brief, 47, 596-599.
Cox, D.S., Cox, A.D., Sturm, L., & Zimet (2010). Behavioral interventions to increase HPV
vaccination acceptability among mothers of young girls. Health Psychology, 29, 29-39.
Cracium, C., Schuz, N., Lippke, S., & Schwarzer, R. (2010). Risk perception moderates how
intentions are translated into sunscreen use. Journal of Behavioral Medicine, 33, 392398.
Cummings, T., Zimet, G.D., Brown, D., Tu, W., Yang, Z., Fortenberry, J.D. et al. (2012).
Reduction of HPV infections through vaccination among at-risk urban adolescents.
Vaccine, 30, 5496-5499.
Daley, E.M., Perrin, K.M., McDermott, R.J., Vamos, C.A., Rayko, H.L., Packing-Ebuen, J.L., et
al. (2011). The psychosocial burden of HPV: a mixed-method study of knowledge,
attitudes, and behaviors among HPV+ women. Journal of Health Psychology, 15, 279290.

53

Daley, E.M., Vamos, C.A., Buhi, E.R., Kolar, S.K., McDermott, R.J., Hernandez, N., &
Fuhrmann, H.J. (2010). Influences on Human Papillomavirus Vaccination Status Among
Female College Students. Journal of Women’s Health, 19, 1885-1891.
Dillard, J.P. (2011). An application of the integrative model to women’s intention to be
vaccinated against HPV: Implications for message design. Health Communication, 26,
479-486.
Dillard, J.P. & Spear, M.E. (2010). Knowledge of human papillomavirus and perceived barriers
to vaccination in a sample of U.S. female college students. Journal of American College
Health, 59, 186-190.
Dosckoch, P. (2012). Young women recognize need for safer sex after HPV vaccination.
Perspectives on Sexual and Reproductive Health, 44, 69-70.
Doherty, K. & Graff Low, K.G. (2008). The effects of a web-based intervention on college
students’ knowledge of human papillomavirus and attitudes toward vaccination.
International Journal of Sexual Health, 20, 223-232.
Dunne, E.F., Unger, E.R., Sternberg, M., McQuillan, G., Swan, D.C., Patel, S.S. et al. (2007).
Prevalence of HPV infection among females in the United States. Journal of the
American Medical Association, 297, 813-819.
Emmons, K.M. & Rollnick, S. (2006). Motivational Interviewing in Health Care Settings:
Opportunities and Limitations. American Journal of Preventive Medicine, 20, 68-74.
Etter, D.J., Zimet, G.D., & Rickert, V.I. (2012). Human papillomavirus vaccine in adolescent
women: a 2012 update. Current Opinions in Obstetrics & Gynecology, 24, 305-310.

54

Fernandez, M.E., McCurdy, S.A., Arvey, S.R., Tyson, S.K., Morales-Campos, D., Flores, B. et al
(2009). HPV knowledge, attitudes, and cultural beliefs among Hispanic men and women
living on the Texas-Mexico border. Ethnicity & Health, 14, 607-624.
Field, A. (2009). Discovering Statistics Using SPSS, 3rd edition. London: SAGE Publications.
Fisher, J.D., & Fisher, W.A. (1992). Changing AIDS-risk behavior. Psychological Bulletin,
111, 455-474.
Fisher, J.D., & Fisher, W.A. (2000). Theoretical Approaches to Individual-Level Change in HIV
Risk Behavior. CHIP Documents, Paper 4.
http://digitalcommons.uconn.edu/chip_docs/4.
Fisher, J.D., Fisher, W.A., Bryan, A.D., & Misovich, S.J. (2002). Information-MotivationBehavioral Skills model-based HIV risk behavior change intervention for inner-city high
school youth. Health Psychology, 21, 177-186.
Fisher, J.D., Fisher, W.A., Misovich, S.J., Kimble, D.L., & Malloy, T.E. (1996). Changing
AIDS-risk behavior: Effects of an intervention emphasizing AIDS risk reduction
information, motivation, and behavioral skills in a college-study population. Health
Psychology, 15, 114-123.
Fisher, W.A., Fisher, J.D., & Harman, J. (2003). The Information-Motivation-Behavioral Skills
mode: A general social Psychological Approach to Understanding and Promoting Health
Behavior. In J. Suls & K.A. Wallston (Eds.), Social Psychological Foundations of
Health and Illness (pp. 82-106). Malden, MA; Blackwell Publishing Ltd.
Fisher, J.D., Fisher, W.A., Bryan, A.D., & Misovich, S.J. (2002). Information-MotivationBehavioral skills model-based HIV risk-behavior change intervention for inner-city high
school youth. Health Psychology, 21, 177-186.

55

Ford, J.L. (2011). Racial and ethnic disparities in Human Papillomavirus awareness and
vaccination among young adult women. Public Health Nursing, 28, 485-493.
Forster, A., Wardle, J., Stephenson, J., & Waller, J. (2010). Passport to promiscuity or lifesaver:
press coverage of HPV vaccination and risky sexual behavior. Journal of Health
Communications, 15, 205-217.
Franco, E.L., Schlecht, N.F., & Saslow, D. (2003). The epidemiology of cervical cancer.
Cancer Journal, 9, 348 - 359.
Garcia, F.A.R. & Saslow, D. (2007). Prophylactic Human Pappillomavirus Vaccination: A
Breakthrough in Primary Cervical Cancer Prevention. Obstetrics and Gynecology
Clinics of North America, 34, 761-781.
Gerend, M.A., Lee, S.C., & Shepherd, J.E. (2007). Predictors of Human papillomavirus
vaccination acceptability among underserved women. Sexually Transmitted Diseases, 34
- 468 - 471.
Gottlieb, S.L., Brewer, N.T., Smith, J.S., Keating, K.M., & Markowitz, L.E. (2009). Availability
of HPV vaccine at medical practices in an area with elevated rates of cervical cancer.
Journal of Adolescent Health, 45, 438-444.
Gotvall, M., Tyden, T., Hoglund, A.T., & Larsson, M. (2010). Knowledge of human
papillomavirus among high school students can be increased by an educational
intervention. International Journal of STD and AIDS, 21, 558-562.
Grant, L.A., Dunne, E.F., Chesson, H. & Markowitz, L.E. (2011). Considerations for human
papillomavirus (HPV) vaccination of mid-adult women in the United States. Vaccine,
29, 2365-2370.

56

Grantham, S., Ahern, L. & Connolly-Ahern, C. (2011). Merck’s One Less Campaign: Using
risk message frames to promote the use of Gardasil in HPV prevention. Communication
Research Reports, 28, 318-326.
Head, K.J. & Cohen, E.L. (2012). Young women’s perspectives on cervical cancer prevention
in Appalachian Kentucky. Qualitative Health Research, 22, 476-487.
Herzog, T.J., Huh, W.K., Downs, L.S., Smith, J.S., & Monk, B.J. (2008). Initial lessons learned
in HPV vaccination. Gynecologic Oncology, 109, S4-S11.
Hollander, D. (2012). Provider recommendation linked to adolescent-females’ HPV
vaccination. Perspectives on Sexual and Reproductive Health, 44, 208-209.
Hopfer, S. (2012). Effects of a narrative HPV vaccination intervention aimed at reaching college
women: A randomized controlled trial. Preventive Science, 13, 173-182.
Hopfer, S. & Clippard, J.R. (2011). College women’s HPV vaccine decision narratives.
Qualitative Health Research, 21, 262-277.
Hsu, Y.Y., Cheng, Y.M., Hsu, K.F., Fetzer, S.., & Chou, C.Y. (2011). Knowledge and beliefs
about cervical cancer and HPV among Taiwanese undergraduate women. Oncology
Nursing Forum, 38, E297-304.
Ingledue, K., Cottrell, R., & Bernard, A. (2004). College women’s knowledge, perceptions and
prevention behaviors regarding human papillomavirus infection and cervical cancer.
American Journal of Health Studies, 19, 28-35.
Jaworski, B.C. & Carey, M.P. (2001). Effects of a brief, theory-based STD-prevention program
for female college students. Journal of Adolescent Health, 29, 417-425.

57

Jensen, S.E., Lehman, B., Antoni, M.H. & Pereira, D.B. (2007). Virally mediated cervical
cancer in the iatrogenically immunocompromised; Applications for
psychoneuroimmunology. Brain, Behavior, and Immunity, 21, 758-766.
Jones, M. & Cook, R. (2008). Intent to receive an HPV vaccine among university men and
women an implications for vaccine administration. Journal of American College Health,
57, 23-31.
Kahn, J.A., Rosenthal, S.L., Jin, Y., Huang, B., Namakydoust, A., & Zimet, G.D. (2008). Rates
of human papillomavirus vaccination, attitudes about vaccination, and human
papillomavirus prevalence in young women. The American College of Obstetricians and
Gynecologists, 111, 1103-1110.
Kalichman, S.C., Picciano, J.F., & Roffman, R.A. (2008). Motivation to reduce HIV risk
behaviors in the context of the information, motivation, and behavioral skills (IMB)
model of HIV prevention. Journal of Health Psychology, 13, 680-689.
Kennedy, A., Sapsis, K.F., Stokley, S., Curtis, C.R., & Gust, D. (2011). Parental attitudes
toward HPV vaccination: Evaluation of an educational intervention, 2008. Journal of
Health Communication, 16, 300313.
Kepka, D.L., Coronado, G.D., Rodriguez, H.P., & Thompson, B. (2012). Development of a
radionovela to promote HPV vaccine awareness and knowledge among Latino parents.
Public Health Rep. , 127, 130-138.
Klug, S.J., Hukelman, M. & Blettner, M. (2008). Knowledge about infection with human
papillomavirus: A systematic review. Preventive Medicine, 46, 87-98.
Kollar, L.M. & Kahn, J.A. (2008). Education about HPV and HPV vaccines in adolescents.
Current Opinions in Obstetrics and Gynecology, 20, 479-483.

58

Krawczyk, A.L., Perez, S., Lau, E., Holcroft, C.A., Amsel, R., Knauper, B., et al. (2012).
Human papillomavirus vaccination intentions and uptake in college women. Health
Psychology, 31, 685-693.
Kwan, T.T., Tam, K.F., Lee, P.W., Chan, K.K., & Ngan, H.Y. (2011). The effect of schoolbased cervical cancer education on perceptions towards HPV vaccination among Hong
Kong Chies adolescent girls. Patient Education and Counseling, 84, 118-122.
Lerman, C., Schwartz, M.D., Lin, T.H., Hughes, C., Narod, S. & Lynch, H. (1997). The
influence of psychological distress on use of genetic testing for cancer risk. Journal of
Consulting and Clinical Psychology, 65, 414-420.
Liddon, N.C., Leichliter, J.S., & Markowitz, L.E. (2012). Human papillomavirus vaccine and
sexual behavior among adolescent and young women. American Journal of Preventive
Medicing, 42, 44-52.
Lu, B., Kumar, A., Castellague, X., & Giuliano, A.R. (2011). Efficacy and safety of
prophylactic vaccines against cervical HPV infection and diseases among women: A
systematic review and meta-analysis. BMC Infectious Diseases, 11, 1-16.
Malo, T.L., Hassani, D., Staras, S.A., Shenkman, E.A., Giuliano, A.R., & Vadaparampil, S.T.
(2012). Do Florida Medicaid providers’ barriers to HPV vaccination vary based on VFC
program participation? Maternal and Chid Health Journal. [Epub ahead of print].
Marek, E., Dergez, T., Rebek-Nagy, G., Kricskovics, A., Kovacs, K., Bozsa, S. et al (2011).
Adolescents’ awareness of HPV infections and attitudes towards HPV vaccination 3
years following the introduction of the HPV vaccine in Hungary. Vaccine, 29, 85918598.

59

Mather, T., McCaffery, K., & Juraskova, I. (2012). Does HPV vaccination affect women’s
attitudes to cervical cancer screening and safe sexual behavior? Vaccine, 30, 3196-3201.
McCave, E.L. (2010. Placing HPV within a social work context: The issue of access to care.
Smith College Studies in Social Work, 80, 377-394.
McRee, A.L., Brewer, N.T., Reiter, P.L., Gottlieb, S.L., & Smith, J.S. (2010). The Carolina HPV
Immunization Attitudes and Beliefs Scale (CHIAS): Scale development and associations
with intentions to vaccinate. Sexually Transmitted Diseases, 37(4): 234-239
Medeiros, R. & Ramada, D. (2011). Knowledge differences between male and female
university students about human papillomavirus (HPV) and cervical cancer: Implications
for health strategies and vaccination. Vaccine, 29, 153-160.
Miller, W.R., & Rollnick, S. (1991). Motivational interviewing: Preparing people to change
addictive behavior. New York: Guilford Press.
Moore, E.W., Smith, W.E., & Folsom, A.R. (2012). F.O.R.E.play: the utility of brief sexual
health interventions among college students. Journal of American College Health, 60,
175-177.
Montalvo, M.T., Lobato, I., Villanueva, H., Borquez, C., Navarrette, D., Abarca, J. et al. (2011).
Prevalence of human papillomavirus in university young women. Oncology Letters, 2,
701-706.
National Cancer Institute. Human Papillomaviruses and Cancer. Available at
http://www.cancer.gov/cancertopics/factsheet/Risk/HPV Accessed May 10, 2011.
Nelson, R. (2007). Politics and power plays behind the HPV vaccine: An effective vaccine is
mired in controversy by mandates. The American Journal of Nursing, 107, 23-24.

60

O’Grady, M.A., Wilson, K. & Harman, J.J. (2009). Preliminary findings from a brief, peer-led
safer sex intervention for college students living in residence halls. Journal of Primary
Prevention, 30, 716-731.
Ohri, L.K. (2007). HPV Vaccine: Immersed in controversy. Annals of pharmacotherapy, 41,
1899-1902.
Osborn, C.Y., Amico, K.R., Cruz, N., O’Connell, A.A., Perez-Escamilla, R., Kalichman, S.C., et
al. (2010). A brief culturally tailored intervention for Puerto Ricans with type 2 diabetes.
Health Education and Behavior, 37, 849-862.
Patel, D.A., Zochowski, M., Peterman, S., Dempsey, A., Ernst, S., & Dalton, V.K. (2012).
Human papillomavirus vaccine intent and uptake among female college students.
Journal of American College Health, 60, 151-161.
McNair, R., Power, J., & Carr, S. (2009). Comparing knowledge and perceived risk related to
the human papillomavirus among Australian women of diverse sexual orientations. Aust.
N. Z. Journal of Public Health, 33, 87-93.
Quinn, G.P., Murphy, D., Malo, T.L., Christie, J., & Vadaparampil, S.T. (2012). A national
survey about human papillomavirus vaccination: what we didn’t ask, but physicians
wanted us to know. Journal of Pediatric and Adolescent Gynecology, 25, 254-258.
Revzina, N.V. & DiClemente, R.J. (2005). Prevalence and incidence of human papillomavirus
infection in women in the USA: A systematic review. International Journal of STD and
AIDs, 16, 528-537.
Roberts, M.E., Gerrard, M., Reimer, R., & Gibbons, F.X. (2010). Mother-daughter
communication and HPV vaccine uptake by college-students. Pediatrics, 125, 982-989.

61

Rosenthal, S.L., Weiss, T.W., Zimet, G.D., Ma, L., Good, M.B., & Vichnin, M.D. (2011).
Predictors of HPV vaccine uptake among women aged 19-26: Importance of a
physician’s recommendation. Vaccine, 29, 890-895.
Sandfort, J.R. & Pleasant, A. (2009). Knowledge, attitudes, and informational behaviors of
college students in regard to the human papillomavirus. Journal of American College
Health, 58, 141-149.
Schwartz, J.L., Caplan, A.L., Faden, R.R., & Sugarman, J. (2007). Lessons from the failure of
HPV vaccine state requirements. Clinical Pharamcology and Therapy, 82, 760-763.
Schwarzer, R.L. & Luszczynska, A.S. (2011). Mechanisms of health behavior change in persons
with chronic illness or disability: The Health Action Process Approach (HAPA).
Rehabilitation Psychology, 56, 161-170.
Shavitt, S., Vargas, P., & Lowrey, P. (2004). Exploring the role of memory for self-selected ad
experiences: Are some advertising media better liked than others? Psychology and
Marketing, 21, 1011-1032.
Singh, S. (2003). Study of the effect of information, motivation, and behavioral skills (IMB)
intervention in changing AIDs risk behavior in female university students. AIDS Care,
15, 71-76.
Smith, J.S., Melendy, A., Rana, R.K., & Pimenta, J.M. (2008). Age-specific prevalence of
infection with human papillomavirus in females: A global review. Journal of Adolescent
Health, 43, S5-S25.
Tan, W., Viera, A.J., Rowe-West, B., Grimshaw, A., Quinn, B., & Walter, E.B. (2011). The
HPV vaccine: Are dosing recommendations being followed? Vaccine, 29, 2548-2554.

62

Tsau, K., Reutzel, T.J., Wang, S., Quinones, A., Nguyen, P., Hasan, S., & Workman, G. (2010).
The knowledge levels and opinions of biomedical students regarding the HPV
quadrivalent (types 6, 11, 16 and 18) recombinant vaccine. Journal of Pharmacy
Practice, 24, 223-234.
Vanderpool, R.C., Casey, B.R., & Crosby, R.A. (2011). HPV-related risk perceptions and HPV
vaccine uptake among a sample of rural women. Journal of Community Health, 36, 903909.
Veldhuijzen, N., Snijders, P.J.F., Reiss, P., Meijer, C.J.L.M., van de Wiggert, J.H.H.M. (2010).
Factors affecting transmission of mucosal human papillomavirus. Lancet Infectious
Diseases, 10, 862-874.
Villa, L.L. (2006). Prophylactic HPV vaccines: Reducing the burden of HPV-related diseases.
Vaccine, 24S1, s1/23-s1/28.
Vogtmann, E., Harlow, S.D., Cruz Valdez, A.C., Cruz Valdez, J.C., & Lazcano Ponce, E.
(2011). HPV knowledge in Mexican college students: implications for intervention
programmes. Health, Social Care, and Community, 19, 148-157.
Waller, J., Marlow, L.A.V., & Wardle, J. (2007). The association between knowledge of HPV
and feelings of stigma, shame, and anxiety. Sexually Transmitted Infections, 83, 155159.
Weinstein, N.D., Lyon, J.E., Sandman, P.M., & Cuite, C.L. (1998). Experimental evidence for
stages of health behavior change: the precaution adoption process model applied to home
radon testing. Health Psychology, 17, 445-453.

63

Wong, L.P. & Sam, I.C. (2010). Ethnically diverse female university students knowledge and
atttitudes toward human papillomavirus (HPV), HPV vaccination and cervical cancer.
European Journal of Obstetrics and Gynecology and Reproductive Biology, 148, 90-95.
Wusu, O. (2011). Adolescents HIV risk perception and sexual behavior in Lago Metropolis,
Nigeria. An International Journal, 19, 227-245.
Zimet, G.D., Stupiansky, N.W., Weiss, T.W., Rosenthal, S.L., Good, M.B., & Vichnin, M.D.
(2011). Influence of patient’s relationship status and HPV history on physicians’
decisions to recommend HPV vaccination. Vaccine, 29, 378-381.

64

Table 1
Participant Demographic Information
N = 62

% Responders (n)

Age mean (range)

19.21 (18-26)
18-21
22-26

90.3 (n = 56)
9.7 (n = 6)

Race/Ethnicity

White/Caucasian
Black/African American
Asian
Hispanic
Other (unidentified multi-racial)

66.1 (n = 41)
8.1 (n = 5)
21.0 (n = 13)
21.0 (n = 13)
4.8 (n = 3)

Education

Freshman
Sophomore
Junior
Senior

48.4 (n = 30)
25.8 (n = 16)
16.1 (n = 10)
9.7 (n = 6)

Work

No
Yes
Part Time
Summer

48.4 (n = 30)
51.6 (n = 32)
35.5 (n = 22)
16.1 (n = 10)

Family Income

< 40,000
40,000 - 74,999
75,000 - 150,000
>150,000

23.3 (n = 14)
18.3 (n = 11)
41.7 (n = 25)
16.7 (n = 10)

Religion

None
Catholic
Protestant
Islamic
Jewish
Other

24.2 (n = 15)
32.3 (n = 20)
9.7 (n = 6)
3.2 (n = 2)
3.2 (n = 2)
27.4 (n = 17)

Sexual Orientation

Heterosexual
Bisexual

98.4 (n = 61)
1.6 (n = 1)
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Table 2
General Health Information
N = 62
Health Insurance

% Responders (n)
No
Yes
No
Yes

8.1 (n = 5)
91.9 (n = 57)
12.9 (n = 8)
87.1 (n = 54)

Past Mental Health Diagnosis

No
Yes

87.1 (n = 54)
12.9 (n = 8)

Past/Current Medical Diagnosis

No
Yes

88.7 (n = 55)
11.3 (n = 7)

Past Familial History of Cancer

No
Yes

40.3 (n = 25)
59.7 (n = 37)

Past Pap Screen

No
Yes

72.6 (n = 45)
27.4 (n = 17)

*Age First Pap

Younger than 16
16 - 19 years old
20 +

5.9 (n = 1)
88.2 (n = 15)
5.9 (n = 1)

*Last Pap Screen

< 6 months ago
~ 6 months to 1 year ago
~ 1-2 years ago
> 2 years ago

29.4 (n = 5)
35.0 (n = 6)
29.4 (n = 5)
5.8 (n = 1)

History of Genital Warts

No
Yes

98.4 (n = 61)
1.6 (n = 1)

Drugs

No
Yes

90.3 (n = 56)
9.7 (n = 6)

Exercise

No
Yes

27.4 (n = 17)
72.6 (n = 45)

Alcohol Use

No
Yes

48.4 (n = 30)
51.6 (n = 32)

Regular Physician

Note. *Percentages calculated based on number of pap screen completers only
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Table 3
Cervical Cancer Risk Behaviors
N = 62

% Responders (n)

History of Sexually Transmitted
Diseases (STDs)

No
Yes

96.8 (n = 60)
3.2 (n = 2)

Oral Contraceptive Use

No
Yes

75.8 (n = 47)
22.6 (n = 14)

Sexual Experience Status

Never Had Sex
Yes Sex

40.3 (n = 25)
59.7 (n = 37)

*No current relationship
*Current relationship

35.1 (n = 13)
64.9 (n = 24)

*Age at First Sexual Intercourse

12 - 14 years
15 - 17 years
18 +

5.4 (n = 2)
56.8 (n = 21)
37.8 (n = 14)

*Number of Sexual Partners
Past Year

0
1
2-4
5-7
>8

5.4 (n = 2)
73.0 (n = 27)
13.5 (n = 5)
5.4 (n = 2)
2.7 (n = 1)

*Number of Sexual Partners
Lifetime

1
2-4
5-7
>8

45.9 (n = 17)
32.4 (n = 12)
8.1 (n = 3)
13.5 (n = 5)

*Frequency Condom Use

Rarely
Sometimes
Usually
Always

10.8 (n = 4)
8.1 (n = 3)
37.8 (n = 14)
37.8 (n = 14)

Past Cigarette Smoking

No
Yes

79.0 (n = 49)
21.0 (n = 13)

Ever Delay Getting Pap Test

No
Yes

58.1 (n = 36)
32.3 (n = 20)

Note. *Percentages calculated based on total number of sexually active participants only
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Table 4
Sources of Information about the Human Papillomavirus (HPV) Vaccine

No
Yes

% Responders
(n)
12.9 (n = 8)
87.1 (n = 54)

Ever Had HPV Test

No
Yes

91.9 (n = 57)
8.1 (n = 5)

Ever Heard of HPV Vaccine

No
Yes

21.0 (n = 13)
79.0 (n = 49)

N = 62
Ever Heard of HPV

PCP
Gynecologist
Other Doctor/Nurse
TV
Radio
Friend
Family
Magazine
Internet
Flyer

27.4 (n = 17)
22.5 (n = 14)
33.9 (n = 21)
50.0 (n = 31)
3.2 (n = 2)
35.5 (n = 22)
25.8 (n = 16)
16.1 (n = 10)
14.5 (n = 9)
6.5 (n = 4)

Recommendation to Vaccinate

PCP
Gynecologist

56.5 (n = 35)
22.6 (n = 14)

Preferred source of Vaccine
Information

Mom
Friends
Doctor
School
Internet
Radio
Newspaper
Commercial

9.7 (n = 6)
4.8 (n = 3)
83.9 (n = 52)
3.2 (n = 2)
21.0 (n = 13)
3.2 (n = 2)
6.5 (n = 4)
6.5 (n = 4)

Perceived Gardasil Knowledge

Nothing at all
A little
A Moderate Amount

17.7 (n = 11)
59.7 (n = 37)
22.6 (n = 14)

Received at least one Gardasil dose

No
Yes

83.9 (n = 52)
16.1 (n = 10)
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Table 5
General Knowledge of Human Papillomavirus (HPV) and Cervical Cancer

% Correct (n)
The virus associated with cervical cancer is transmitted by sex.

72.5 (n = 45)

Cervical cancer and pre-cancer cells are associated with HPV.

71.0 (n = 44)

Cervical cancer can be diagnosed by Pap tests.

74.2 (n = 46)

CC prevention requires delayed sex, pap tests, and condom use.

74.2 (n = 46)

HPV can cause genital warts.

40.3 (n = 25)

HPV can live in skin without causing growths or changes.

48.4 (n = 30)

Multiple sex partners increases risk for cervical cancer.

77.4 (n = 48)

Having genital warts increases risk for cervical cancer. (false)

9.7 (n = 6)

Having sex before age 18 increases risk for cervical cancer.

45.2 (n = 28)

Taking illegal drugs increases risk for cervical cancer. (false)

41.9 (n = 26)

Having contracted any sexually transmitted disease increases
cervical cancer risk.

71.0 (n = 44)

Smoking cigarettes increases risk for cervical cancer.

12.9 (n = 8)

Poor diet or nutrition increases risk for cervical cancer. (false)

45.2 (n = 28)

Using tampons increases risk for cervical cancer. (false)

71.0 (n = 44)

Using oral contraceptives increases risk for cervical cancer.
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4.8 (n = 3)

Table 6
General Knowledge of Human Papillomavirus (HPV) Vaccine

% Correct (n)

Girls/women who get the HPV vaccine need less frequent pelvic
exams. (false)

91.9 (n = 57)

Girls/women who get the HPV vaccine do not have to get Pap
Smears. (false)

98.4 (n = 61)

The HPV vaccine protects against all sexually transmitted infections.
96.8 (n = 60)
(false)

The HPV vaccine protects against cervical cancer. (true)

71.0 (n = 44)

Girls/women who get the HPV vaccine can worry less about all
sexually transmitted diseases. (false)

83.9 (n = 52)

Girls who get the HPV Vaccine no longer need condoms during
sex. (false)

100.0 (n = 62)
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Table 7
Predictors of Cervical Cancer Preventive Behaviors

Model 1
Variable

Model 2

B

SE B

b

B

SE B

b

Age

.06

.15

.05

.06

.14

.05

Past Gardasil Dose

.10

.64

.02

-1.79

.60

-.37*

Total Knowledge

.11

.09

.13

Motivation

.18

.37

.11

Intention

.06

.06

.26

Social Norms

.06

.04

.22

Perceived Risk

-.10

.04

-.31*

R2
F for change in R2
*p<.01. **p < .001.

.00

.50

.08

6.43**
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Figure 1. The Information Motivation Behavioral Skills Model

Information about
HPV/CC & Gardasil

Behavioral skills
to get vaccinated

Vaccination & Cancer
Preventive Behaviors

Motivation
to get vaccinated

Figure 1. This figure represents the IMB model as it is applied to Gardasil Vaccination. Adapted
from "The Information-Motivation-Behavioral Skills Model: A General Social Psychological
Approach to Understanding and Promoting HealthBehavior.” by Fisher, Fisher, and Harman
(2003). Application of the Protection Motivation Theory to Genetic Testing for Breast Cancer
Risk. Social Psychological Foundations of Health & lllness (pp. 82-106). Malden, MA;
Blackwell Publishing Ltd.
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Figure 2. Estimated Marginal Means for Total Knowledge Scores for Condition Across Time
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Figure 3. Estimated Marginal Means for Vaccine Knowledge for Condition Across Time
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Figure 4. Estimated Marginal Means for HPV and Cervical Cancer Knowledge for Condition
Across Time
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Figure 5. Estimated Marginal Means for Motivation to get Vaccinated for Condition Across
Time

76

Figure 6. Estimated Marginal Means for Vaccination Intentions for Condition Across Time
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Figure 7. Estimated Marginal Means for Vaccination Attitudes for Condition Across Time
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Figure 8. Estimated Marginal Means for Perceived Social Norms for Vaccination for Condition
Across Time
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Figure 9. Estimated Marginal Means for Perceived Risk of HPV and Cervical Cancer for
Condition Across Time
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Figure 10. Estimated Marginal Means for Self-Efficacy to Get Vaccinated for Condition Across
Time
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Figure 11. Estimated Marginal Means for Perceived Difficulty to get Vaccinated for Condition
Across Time
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Figure 12. Estimated Marginal Means for Perceived Harm of Gardasil Vaccination for
Condition Across Time
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Figure 13. Estimated Marginal Means for Perceived Barriers of Gardasil Vaccination for
Condition Across Time
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Figure 14. Estimated Marginal Means for Perceived Efficacy of Gardasil Vaccine for Condition
Across Time
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Figure 15. Estimated Marginal Means for Perceived Uncertainty Toward Gardasil for Condition
Across Time
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Figure 16. Estimated Marginal Means for Perceived Severity of Vaccination for Condition
Across Time
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